[{"title": "Merck's Munificence: Ex-Schering CEO Fred Hassan Walks Away With $50M", "desc": null, "date": "13/04/2010", "link": "news.google.com/articles/CBMiYGh0dHBzOi8vd3d3LmNic25ld3MuY29tL25ld3MvbWVyY2tzLW11bmlmaWNlbmNlLWV4LXNjaGVyaW5nLWNlby1mcmVkLWhhc3Nhbi13YWxrcy1hd2F5LXdpdGgtNTBtL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNZalk1WmpoR01FSjVhVmh1VFJDQ0FoakRBU2dCTWdhdFJJeU9JUWs=-w200-h112-p-df", "media": "CBS News", "site": null, "reporter": "Jim Edwards", "sentiment": "positive"}, {"title": "Is Elan Earning Its Keep?", "desc": null, "date": "30/09/2011", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL3N0eWxlLzIwMTEtMDktMzAtaXMtZWxhbi1lYXJuaW5nLWl0cy1rZWVwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJlWE5ETlhaTVpsSnpkMnN6VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Campath gets pulled to clear the way for higher-priced Lemtrada | Fierce Pharma", "desc": null, "date": "21/08/2012", "link": "news.google.com/articles/CBMibWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc2FsZXMtYW5kLW1hcmtldGluZy9zYW5vZmktcHVsbHMtY2FtcGF0aC10by1jbGVhci13YXktZm9yLWhpZ2hlci1wcmljZWQtbGVtdHJhZGHSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNPV2R5YkdsVmFrNVlVVGxIVFJDb0FSaXNBaWdCTWdZQklJcWdQd1U=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Some Biogen Idec employees are taking the `disco bus\u2019 to work in Cambridge", "desc": null, "date": "23/07/2013", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3LmJvc3Rvbi5jb20vbmV3cy91bnRhZ2dlZC8yMDEzLzA3LzIzL3NvbWUtYmlvZ2VuLWlkZWMtZW1wbG95ZWVzLWFyZS10YWtpbmctdGhlLWRpc2NvLWJ1cy10by13b3JrLWluLWNhbWJyaWRnZS_SAX9odHRwczovL3d3dy5ib3N0b24uY29tL25ld3MvdW50YWdnZWQvMjAxMy8wNy8yMy9zb21lLWJpb2dlbi1pZGVjLWVtcGxveWVlcy1hcmUtdGFraW5nLXRoZS1kaXNjby1idXMtdG8td29yay1pbi1jYW1icmlkZ2UvP2FtcD0x?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlhMDF4T1dzMU1XSTVZMVZHVFJDNkFSaVBBaWdCTWdZQm9JNkdQQVk=-w200-h112-p-df", "media": "Boston.com", "site": null, "reporter": "Robert Weisman", "sentiment": "negative"}, {"title": "Biogen Idec's ELOCTATE and ALPROLIX Will Grow the Hemophilia Market, a ZoomRx Study Finds", "desc": null, "date": "04/09/2013", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvMjAxMy0wOS0wNC1iaW9nZW4taWRlY3MtZWxvY3RhdGUtYW5kLWFscHJvbGl4LXdpbGwtZ3Jvdy10aGUtaC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXFhVmhGZEV0alFsOUViMUZ4VFJDLUFSaUtBaWdCTWdtRklKTEZvU2ttNUFJ=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "20 Big Pharma and biotech mobile apps - 2013", "desc": null, "date": "21/10/2013", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL3ItZC8yMC1iaWctcGhhcm1hLWFuZC1iaW90ZWNoLW1vYmlsZS1hcHBzLTIwMTPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXhaa3BqWWkwNE5IUlFWM1pWVFJDb0FSaXNBaWdCTWdhNUFvd3lLUWM=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Biogen Idec (Nasdaq: BIIB)", "desc": null, "date": "04/06/2014", "link": "news.google.com/articles/CBMiNmh0dHBzOi8vd3d3Lm5ld3N3ZWVrLmNvbS9ncmVlbi9iaW9nZW4taWRlYy1uYXNkYXEtYmlpYtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVZMV3BrYm5wMU1HTkZOMFZxVFJDM0FSaVRBaWdCTWdhSllJd3d0UVU=-w200-h112-p-df", "media": "Newsweek", "site": null, "reporter": "Rob Verger", "sentiment": "negative"}, {"title": "Acceleron Pharma, Inc. (XLRN) in Focus: Stock Soars 13.6%", "desc": null, "date": "09/12/2014", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2FjY2VsZXJvbi1waGFybWEtaW5jLXhscm4tZm9jdXMtMTEyOTA4MTc2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTBlSEZmTUZOZlRtRktXazlyVFJDM0FSaVRBaWdCTWdrUlpZeUlQcVY3S2dJ=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Sarepta Therapeutics (SRPT) Soars: Stock Up 39.3%", "desc": null, "date": "21/04/2014", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvbmV3cy9zYXJlcHRhLXRoZXJhcGV1dGljcy1zcnB0LXNvYXJzLXN0b2NrLTA1NDkwODcwMy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTBNbE5JVjJoWFNXaEZWMmM0VFJDUUFoaTVBU2dCTWdB=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan", "desc": null, "date": "26/11/2014", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYWxleGlvbnMtYWx4bi1zb2xpcmlzLWdldHMtb3JwaGFuLTIxMTAwMjE5MS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNU5WWGg1VFdOMGVsSlNXRTFIVFJDb0FSaXNBaWdCTWdrQlFKS1dwT2JBUndJ=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Bougainville gets serious about attracting investment", "desc": null, "date": "09/04/2014", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vd3d3LmJ1c2luZXNzYWR2YW50YWdlcG5nLmNvbS9ib3VnYWludmlsbGUtZ2V0cy1zZXJpb3VzLWF0dHJhY3RpbmctaW52ZXN0bWVudC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWZRWGhLY1RCbVdUSk1ZM0o1VFJDaEFSaTRBaWdCTWdrRm9KSjJyQ2FhN1FF=-w200-h112-p-df", "media": "businessadvantagepng.com", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Falls on Concerns Regarding Tecfidera Sales and PML Case", "desc": null, "date": "24/10/2014", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vY2Euc3R5bGUueWFob28uY29tL3N0eWxlL2Jpb2dlbi1mYWxscy1jb25jZXJucy1yZWdhcmRpbmctdGVjZmlkZXJhLTIwMjUwNDY4OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": null, "media": "Yahoo Canada Shine On", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Epizyme Gains on Positive Phase I Data on EPZ-6438", "desc": null, "date": "21/11/2014", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvZXBpenltZS1nYWlucy1wb3NpdGl2ZS1waGFzZS1kYXRhLTIyMTUwMjc5NS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTFMWFpoWkd4UlZHY3dNak4zVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why Biogen (Nasdaq: BIIB) Stock Price - at $400 - Will Still Climb...", "desc": null, "date": "24/04/2015", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vbW9uZXltb3JuaW5nLmNvbS8yMDE1LzA0LzI0L3doeS1iaW9nZW4tbmFzZGFxLWJpaWItc3RvY2stcHJpY2UtYXQtNDAwLXdpbGwtc3RpbGwtY2xpbWItaGlnaGVyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUxaRjlpVmkwM1FqUjNiaTFSVFJESEFSajlBU2dCTWdhQkFZeUpDUXc=-w200-h112-p-df", "media": "Money Morning", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Buoyed by rising tide of Aubagio scripts, Sanofi aims for \u20ac2B in MS sales", "desc": null, "date": "09/11/2015", "link": "news.google.com/articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2J1b3llZC1ieS1yaXNpbmctdGlkZS1vZi1hdWJhZ2lvLXNjcmlwdHMtc2Fub2ZpLWFpbXMtZm9yLSVFMiU4MiVBQzJiLW1zLXNhbGVz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZSbEE1VUZGMVNWZEpPVlJoVFJESUFSaklBU2dCTWdZQmNKYmpLZ2c=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen to cut 11 percent of staff, cancel some drug programs; stock jumps", "desc": null, "date": "21/10/2015", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2Jpb2dlbi1jdXQtMTEtcGVyY2VudC1nbG9iYWwtMTE0NTEyOTY5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWxTbHBGVjJsRlprbFVUVGswVFJDOUFSaUxBaWdCTWdhbGRZak5MUVk=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is Kroger's Stock (KR) Starting To Roll Over?", "desc": null, "date": "20/04/2015", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vd3d3LnNlZWl0bWFya2V0LmNvbS9pcy1rcm9nZXJzLXN0b2NrLXN0YXJ0aW5nLXRvLXJvbGwtb3Zlci1rci0xNDI4OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFSVFZZT1VKak9HMUJXVGxuVFJDMUFSaVhBaWdCTWdZRmM0N0Z2UVE=-w200-h112-p-df", "media": "See It Market", "site": null, "reporter": "Mike Zaccardi", "sentiment": "negative"}, {"title": "FDA updates label for Novartis' MS pill Gilenya after reports of brain infection", "desc": null, "date": "05/08/2015", "link": "news.google.com/articles/CBMid2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcmVndWxhdG9yeS9mZGEtdXBkYXRlcy1sYWJlbC1mb3Itbm92YXJ0aXMtbXMtcGlsbC1naWxlbnlhLWFmdGVyLXJlcG9ydHMtb2YtYnJhaW4taW5mZWN0aW9u0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5ZV3BUTlhaYVpWSlVUbEpKVFJERUFSaklBU2dCTWdZSlpKWm1LZ2c=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "JPM and BAC Rose Due to the Likelihood of a Rate Hike", "desc": null, "date": "19/11/2015", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vY2Euc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9qcG0tYmFjLXJvc2UtZHVlLWxpa2VsaWhvb2QtMTgyMzA1NDU1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNiR1pFTFZaT0xUUmxSMlZOVFJDM0FSaVRBaWdCTWdhVlE1WnBKUWc=-w200-h112-p-df", "media": "Yahoo Canada Shine On", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is This a Biotech Bubble?", "desc": null, "date": "27/03/2015", "link": "news.google.com/articles/CBMiPWh0dHBzOi8vbW9uZXltb3JuaW5nLmNvbS8yMDE1LzAzLzI3L2lzLXRoaXMtYS1iaW90ZWNoLWJ1YmJsZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNOVFptYWpoUk0yaHVXWHBWVFJESEFSajlBU2dCTWdZRkVZNG1KZ1k=-w200-h112-p-df", "media": "Money Morning", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biotech Giant Biogen To Spin-Off Bioverativ", "desc": null, "date": "21/12/2016", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvam9lY29ybmVsbC8yMDE2LzEyLzIxL2Jpb3RlY2gtZ2lhbnQtYmlvZ2VuLXRvLXNwaW4tb2ZmLWJpb3ZlcmF0aXYv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVFTRnBPVUZGMU0yZGZXRFJEVFJDdUFSaWlBaWdCTWdNaEJBbw=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": "Joe Cornell", "sentiment": "positive"}, {"title": "Boeing Institute of International Business Honors Hussmann Award Recipients", "desc": null, "date": "12/10/2016", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3LnNsdS5lZHUvbmV3cy8yMDE2L29jdG9iZXIvaHVzc21hbm4tYXdhcmQtcmVjaXBpZW50cy1ob25vcmVkLWF0LWNlcmVtb255LnBocNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVNMVFJDVldKRVlUUmpZMWR2VFJDM0FSaVRBaWdCTWdNQmNCQQ=-w200-h112-p-df", "media": "Saint Louis University", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "UPDATED: Biogen targets Cambridge plant, up to 285 jobs at risk", "desc": null, "date": "17/06/2016", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Jpb2dlbi1jbG9zaW5nLXBsYW50LWF0LWNhbWJyaWRnZS1tYS1ocS1jdXR0aW5nLXVwLXRvLTI4NS1qb2Jz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTZha2hvVUd0elZqQm1TekEyVFJDb0FSaXNBaWdCTWdNQmtRQQ=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Eric Palmer", "sentiment": "negative"}, {"title": "Biogen aims for neuro 'transformative era' but drops late-stage MS candidate", "desc": null, "date": "26/10/2016", "link": "news.google.com/articles/CBMia2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYmlvZ2VuLWFpbXMtZm9yLW5ldXJvLXRyYW5zZm9ybWF0aXZlLWVyYS1idXQtZHJvcHMtcGhpaWktbXMtY2FuZGlkYXRl0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTZha2hvVUd0elZqQm1TekEyVFJDb0FSaXNBaWdCTWdNQmtRQQ=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Coming soon to the Nasdaq: Biogen's hemophilia spinoff - Boston Business Journal", "desc": null, "date": "26/12/2016", "link": "news.google.com/articles/CBMiZGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9ib3N0b24vbmV3cy8yMDE2LzEyLzI2L2NvbWluZy1zb29uLXRvLXRoZS1uYXNkYXEtYmlvZ2Vucy1oZW1vcGhpbGlhLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVJlbmxXTUZWUFpEUXhNVE5NVFJDVEFoaTNBU2dCTWdhaFJaRE1JUWs=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Max Stendahl", "sentiment": "positive"}, {"title": "Boeing Institute of International Business Hosts Southwest Case Competition", "desc": null, "date": "17/11/2016", "link": "news.google.com/articles/CBMiRWh0dHBzOi8vd3d3LnNsdS5lZHUvbmV3cy8yMDE2L25vdmVtYmVyL3NvdXRod2VzdC1jYXNlLWNvbXBldGl0aW9uLnBocNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUVWM1p0TW5abWNFUm5iMVJWVFJDM0FSaVRBaWdCTWdrQklaS2ttQ3E1S3dJ=-w200-h112-p-df", "media": "Saint Louis University", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen switches to Medidata Rave, tipping balance of eClinical power further still", "desc": null, "date": "21/07/2016", "link": "news.google.com/articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2l0L2Jpb2dlbi1zd2l0Y2hlcy10by1tZWRpZGF0YS1yYXZlLXRpcHBpbmctYmFsYW5jZS1lY2xpbmljYWwtcG93ZXItZnVydGhlci1zdGlsbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDJORzVzUkdwb1QzUmhlVU5hVFJDb0FSaXNBaWdCTWdtaEFhTFZsS3FLQXdN=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "CDMO Patheon positions itself for $625M IPO next week", "desc": null, "date": "12/07/2016", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9jZG1vLXBhdGhlb24tcG9zaXRpb25zLWl0c2VsZi1mb3ItNjI1bS1pcG8tbmV4dC13ZWVr0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpXVTFhWVMxdWVGcFlSR3hoVFJDb0FSaXNBaWdCTWdZcGdJeHZ3UVE=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Joseph Keenan", "sentiment": "negative"}, {"title": "FDA approves AbbVie/Biogen's monthly MS jab, but with safety warnings", "desc": null, "date": "28/05/2016", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvZmRhLWFwcHJvdmVzLWFiYnZpZS1iaW9nZW4tcy1tb250aGx5LW1zLWphYi1idXQtc2FmZXR5LXdhcm5pbmdz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXBhVmg0Tlc1UWN6TnZlbGh2VFJDb0FSaXNBaWdCTWdPQmtRQQ=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "How Biogen Inc (BIIB) Stock Could Gain Another 25%", "desc": null, "date": "08/02/2017", "link": "news.google.com/articles/CBMiSGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAxNy8wMi9iaW9nZW4taW5jLWJpaWItc3RvY2stZ2Fpbi1hbm90aGVyLTI1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFWWHBGYkdwQ05rTnlTa2RGVFJDbUFSaXZBaWdCTWdhQlJZVHNvUUk=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Richard Saintvilus", "sentiment": "positive"}, {"title": "Company News For August 29, 2017", "desc": null, "date": "29/08/2017", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2NvbXBhbnktbmV3cy1hdWd1c3QtMjktMjAxNy0xNDM4MDI4MTAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUtSbko0TlhOWVl6aFJOMmRpVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Biogen Inc (BIIB) Stock Can Help You Earn Income From Thin Air", "desc": null, "date": "05/06/2017", "link": "news.google.com/articles/CBMiP2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAxNy8wNi9iaW9nZW4taW5jLWJpaWItc3RvY2staW5jb21lL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTFWWHBGYkdwQ05rTnlTa2RGVFJDbUFSaXZBaWdCTWdB=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Nicolas Chahine", "sentiment": "negative"}, {"title": "Deutsche Bank's Take On Big Pharma: 3 Buys And A Hold - Esperion Therapeutics (NASDAQ:ESPR), Gilead Scien", "desc": null, "date": "23/06/2017", "link": "news.google.com/articles/CBMiKGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzk2NDY2NjfSASxodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvOTY0NjY2Nw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Wayne Duggan", "sentiment": "negative"}, {"title": "Your first trade for Monday, January 17", "desc": null, "date": "17/01/2017", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vc2cubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2ZpcnN0LXRyYWRlLW1vbmRheS1qYW51YXJ5LTE3LTE0MDYyMjg0My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5VMnh1YW5aMVQwMTRWWFpRVFJDb0FSaXNBaWdCTWdZQmRZVE5xUWM=-w200-h112-p-df", "media": "Yahoo Singapore News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 ETFs to Watch Out for on Biotech Earnings", "desc": null, "date": "31/07/2017", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvMy1ldGZzLXdhdGNoLWJpb3RlY2gtZWFybmluZ3MtMDQyNjA0NjU4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhjRGd0TlVKMGIzTkNPVU5FVFJDM0FSaVRBaWdCTWdZRklKNWtuQW8=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "All eyes will be on Biogen Alzheimer\u2019s results this week \u2014 and the stock could swing wildly", "desc": null, "date": "25/07/2018", "link": "news.google.com/articles/CBMihQFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vc3RvcnkvYWxsLWV5ZXMtd2lsbC1iZS1vbi1iaW9nZW4tYWx6aGVpbWVycy1yZXN1bHRzLXRoaXMtd2Vlay1hbmQtdGhlLXN0b2NrLWNvdWxkLXN3aW5nLXdpbGRseS0yMDE4LTA3LTIz0gGJAWh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9hbXAvc3RvcnkvYWxsLWV5ZXMtd2lsbC1iZS1vbi1iaW9nZW4tYWx6aGVpbWVycy1yZXN1bHRzLXRoaXMtd2Vlay1hbmQtdGhlLXN0b2NrLWNvdWxkLXN3aW5nLXdpbGRseS0yMDE4LTA3LTIz?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdSVFo2V1dveVNERllSMHN5VFJDSEFSajFBaWdCTWdhQmdKYkVyZ2M=-w200-h112-p-df", "media": "MarketWatch", "site": null, "reporter": "Emma Court", "sentiment": "positive"}, {"title": "Biogen Spin-Off Bioverativ To Be Acquired", "desc": null, "date": "31/01/2018", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvam9lY29ybmVsbC8yMDE4LzAxLzMxL2Jpb2dlbi1zcGluLW9mZi1iaW92ZXJhdGl2LXRvLWJlLWFjcXVpcmVkL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTZTVFJhYWtKdWQwUTNNME5VVFJDTkFSam1BaWdCTWdZZEpwSXJHZ3M=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": "Joe Cornell", "sentiment": "negative"}, {"title": "Why Biogen's Stock Rebound Is Good News for Biotechs", "desc": null, "date": "25/04/2018", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vbmV3cy93aHktYmlvZ2Vucy1zdG9jay1yZWJvdW5kLWdvb2QtbmV3cy1iaW90ZWNocy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNDJTbTUzZEdrM1ZEUjVkbFV4VFJDb0FSaXJBaWdCTWdzQkVKS2lDdXcwSzVvZ3Fn=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Michael J. Kramer", "sentiment": "positive"}, {"title": "Biogen pays $27.5M upfront for 2 AliveGen muscle drugs", "desc": null, "date": "24/07/2018", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYmlvZ2VuLXBheXMtMjctNW0tdXBmcm9udC1mb3ItdHdvLWFsaXZlZ2VuLW11c2NsZS1kcnVnc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXZlalJPVkZnd1MzRndjRFEwVFJDb0FSaXNBaWdCTWdPQmdRQQ=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": "Phil Taylor", "sentiment": "negative"}, {"title": "Company News For Jul 25, 2018", "desc": null, "date": "25/07/2018", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2NvbXBhbnktbmV3cy1qdWwtMjUtMjAxOC0xNDQ5MDI1ODkuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDJSMVJmUmxoQk9WaEJRVFpVVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Why Overvalued Gilead May Fall 10%", "desc": null, "date": "12/03/2018", "link": "news.google.com/articles/CBMiRGh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vbmV3cy93aHktb3ZlcnZhbHVlZC1naWxlYWQtbWF5LWZhbGwtMTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpWMGR5WDNnemVHSnNTVVZRVFJDMUFSaVhBaWdCTWdhaFFvaHdOUVk=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Michael J. Kramer", "sentiment": "negative"}, {"title": "Stada Arz raids big pharma for new management team members", "desc": null, "date": "20/04/2018", "link": "news.google.com/articles/CBMiXmh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9zdGFkYS1yYWlkcy1iaWctcGhhcm1hLWZvci1uZXctbWFuYWdlbWVudC10ZWFtLW1lbWJlcnPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlUVmRTUVdSSlZ6TnlTRUZaVFJDM0FSaVRBaWdCTWdZcEpwcnRuUWs=-w200-h112-p-df", "media": "The Pharma Letter", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is Biogen Inc. a Buy?", "desc": null, "date": "14/03/2018", "link": "news.google.com/articles/CBMiRGh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2Jpb2dlbi1pbmMtYnV5LTEwMDMwMDg0OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU1UMUZzT0Zsb2RVZDNMV0prVFJDOEFSaU1BaWdCTWdZQlFJb29xUVk=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 Biotech Stocks With Rising Earnings Estimates Post Q4", "desc": null, "date": "13/03/2018", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzLzMtYmlvdGVjaC1zdG9ja3MtcmlzaW5nLWVhcm5pbmdzLTE1MDQwMzc1MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUliV3BJWVVoS2VuaGxSblpyVFJDeEFSaWNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Exclusive: Big Pharma returning to U.S. price hikes in January after pause", "desc": null, "date": "19/12/2018", "link": "news.google.com/articles/CBMib2h0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvZXhjbHVzaXZlLWJpZy1waGFybWEtcmV0dXJuaW5nLXUtcHJpY2UtaGlrZXMtamFudWFyeS0wMDQ4MjE4MDUtLWZpbmFuY2UuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXFhVmhGZEV0alFsOUViMUZ4VFJDLUFSaUtBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib", "desc": null, "date": "21/12/2018", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9hYmJ2aWUtYWJidi1zZWVrcy1hcHByb3ZhbC1yYS0xOTUyMDc0NzcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTVWVkIwZWtOeUxUWXhhbXRMVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Stock Running in Place Despite Strong Quarter", "desc": null, "date": "29/01/2019", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vYmlvZ2VuLXJ1bm5pbmctaW4tcGxhY2UtZGVzcGl0ZS1zdHJvbmctcXVhcnRlci00NTg0OTM30gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDRXRWN3UVc5cFMzQnpPWEZPVFJDcEFSaXFBaWdCTWdZQlVZYVdtQWs=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Alan S. Farley", "sentiment": "positive"}, {"title": "Biogen (BIIB) Stock Surges After Alzheimer Drug Reversal With FDA", "desc": null, "date": "22/10/2019", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDE5LTEwLTIyL2Jpb2dlbi13aWxsLXRha2UtYWx6aGVpbWVyLXMtdHJlYXRtZW50LXRvLWZkYS1yZXZpdmluZy1ob3Bl0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXVlV0V4YkVGT2JFdGtiMEpFVFJDM0FSaVRBaWdCTWdhbGxKS010UVk=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Riley Griffin & Michelle Cortez", "sentiment": "negative"}, {"title": "After Biogen's big Alzheimer's drug data reveal, observers remain divided - Boston Business Journal", "desc": null, "date": "05/12/2019", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9ib3N0b24vbmV3cy8yMDE5LzEyLzA1L2FmdGVyLWJpb2dlbnMtYmlnLWFsemhlaW1lcnMtZHJ1Zy1kYXRhLXJldmVhbC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWxTVlZ0UTFBd1MwSTRTMnhTVFJDb0FSaXNBaWdCTWdZQnM0SkozZ0U=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Allison DeAngelis", "sentiment": "positive"}, {"title": "Alzheimer's drug failure leaves Biogen in a precarious place", "desc": null, "date": "21/03/2019", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDE5LzAzLzIxL2FsemhlaW1lcnMtZHJ1Zy1mYWlsdXJlLWJpb2dlbi1wcmVjYXJpb3VzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXJXR0ZWWjJ0UWExaExjMkoxVFJEaEFSamhBU2dCTWdZbHdKQ3V3QVU=-w200-h112-p-df", "media": "STAT", "site": null, "reporter": "Adam Feuerstein & Matthew Herper", "sentiment": "positive"}, {"title": "Biogen Stock Rises A Fraction As Investors Digest Gene Therapy Buy", "desc": null, "date": "05/03/2019", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2Jpb2dlbi1zdG9jay1yaXNlcy1pbnZlc3RvcnMtZGlnZXN0LWdlbmUtdGhlcmFweS1idXkv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUplRzFHVkY5YU1XZDRibE5QVFJDb0FSaXNBaWdCTWdhRklwcjBJQWs=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "Biogen Replenishes Eye Disease Gene Therapy Pipeline with Planned $877M Nightstar Acquisition", "desc": null, "date": "04/03/2019", "link": "news.google.com/articles/CBMijgFodHRwczovL3d3dy5nZW5lbmduZXdzLmNvbS90b3BpY3MvZ2Vub21lLWVkaXRpbmcvYmlvZ2VuLXJlcGxlbmlzaGVzLWV5ZS1kaXNlYXNlLWdlbmUtdGhlcmFweS1waXBlbGluZS13aXRoLXBsYW5uZWQtODc3bS1uaWdodHN0YXItYWNxdWlzaXRpb24v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUxOM2haYVZwckxWTkJUMnBEVFJEREFSaURBaWdCTWdhZFVwS05xUWM=-w200-h112-p-df", "media": "Genetic Engineering & Biotechnology News", "site": null, "reporter": "Alex Philippidis", "sentiment": "negative"}, {"title": "Biogen\u2019s Q4 results beat estimates; revenues up 7%", "desc": null, "date": "29/01/2019", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYmlvZ2Vucy1xNC1yZXN1bHRzLWJlYXQtZXN0aW1hdGVzLXJldmVudWVzLXVwLTcv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXJhamgyYVcxcVUzRm9UaTFrVFJDUkFoaTVBU2dCTWdtQk1Zb0ZSbVJNalFF=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Biogen hit by 'transformative failure' as it cans aducanumab tests", "desc": null, "date": "21/03/2019", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYmlvZ2VuLWFuZC1laXNhaS1yb2NrZWQtYXMtYWR1Y2FudW1hYi10dXJucy1vdXQtdG8tYmUtYS1kdWTSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iNkNnNWZXa3BqYUZwc1RrTk1WWGczVFJDb0FSaXNBaWdCTWc0RnNvTGlRS0lqWEtnSkpzYlVJQQ=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen to Acquire Gene-Therapy Company Nightstar for $800M", "desc": null, "date": "05/03/2019", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYmlvZ2VuLWFjcXVpcmUtZ2VuZS10aGVyYXB5LWNvbXBhbnktMjE1MzA5NzI5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTZjMmhET1dndFpISkpVUzFLVFJDb0FSaXNBaWdCTWdZZFJKQndIUWs=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AbbVie's Allergan Deal Sets Up Another Trade In Big Biotech", "desc": null, "date": "26/06/2019", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vcHJvLnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL2FiYnZpZS1zLWFsbGVyZ2FuLWRlYWwtc2V0cy11cC1hbm90aGVyLXRyYWRlLWluLWJpZy1iaW90ZWNoLTE0OTk5MTI30gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNHRVRmhTY1dWdlRIRXhkSEJFVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Bret Jensen", "sentiment": "negative"}, {"title": "Stock Market Today: Stocks Rally Ahead of Big Earnings Week", "desc": null, "date": "21/10/2019", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAxOS8xMC9zdG9jay1tYXJrZXQtdG9kYXktc3RvY2tzLXJhbGx5LWFoZWFkLW9mLWJpZy1lYXJuaW5ncy13ZWVrL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUNVVVl6UkhkeFIyNW5hbTVuVFJDb0FSaXNBaWdCTWdtTk1veElIU2RyY3dF=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Bret Kenwell", "sentiment": "negative"}, {"title": "Biogen, Alkermes win FDA approval for oral multiple sclerosis drug Vumerity", "desc": null, "date": "31/10/2019", "link": "news.google.com/articles/CBMic2h0dHBzOi8vd3d3LmJpb3dvcmxkLmNvbS9hcnRpY2xlcy80MzA4NTUtYmlvZ2VuLWFsa2VybWVzLXdpbi1mZGEtYXBwcm92YWwtZm9yLW9yYWwtbXVsdGlwbGUtc2NsZXJvc2lzLWRydWctdnVtZXJpdHnSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNU1kREZhYlVKWmR6RktTekExVFJEQ0FSaURBaWdCTWd1Tk1vSkxHZVNwRDJtUm1R=-w200-h112-p-df", "media": "BioWorld Online", "site": null, "reporter": "Michael Fitzhugh", "sentiment": "negative"}, {"title": "Where to Buy Booming Biotech ETFs", "desc": null, "date": "03/12/2019", "link": "news.google.com/articles/CBMiRmh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vd2hlcmUtdG8tYnV5LWJvb21pbmctYmlvdGVjaC1ldGZzLTQ3Nzc5NzbSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVZVbHBGY2xwWlgyTnpZbmRSVFJDMEFSaVhBaWdCTWdZQk1JZ2hvd2c=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Tim Smith", "sentiment": "negative"}, {"title": "Stocks - Tesla, AT&T, Amazon, Facebook Rise in Premarket", "desc": null, "date": "04/03/2019", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3Mvc3RvY2tzLXRlc2xhLXQtYW1hem9uLWZhY2Vib29rLTA4MzAwMDU1Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUthMnBTU2tJelVtbGxOV2xWVFJDM0FSaVRBaWdCTWdZQlJKU3VKUWc=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Should You Buy Viking Therapeutics After Gilead Drug Failure?", "desc": null, "date": "14/02/2019", "link": "news.google.com/articles/CBMiZGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAxOS8wMi9idXktdmlraW5nLXRoZXJhcGV1dGljcy12a3R4LXN0b2NrLWFmdGVyLWdpbGVhZC1kcnVnLWZhaWx1cmUtc2ltZy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXFTakZ3ZUZWSGNFZFhRemhyVFJDbUFSaXZBaWdCTWdhWlFaTFZIQWs=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Bret Kenwell", "sentiment": "negative"}, {"title": "3 Big Stock Charts for Friday: Microsoft, Texas Instruments, and Box", "desc": null, "date": "25/10/2019", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAxOS8xMC8zLWJpZy1zdG9jay1jaGFydHMtZnJpZGF5LW1pY3Jvc29mdC10ZXhhcy1pbnN0cnVtZW50cy1ib3gv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDFWMnBRU0daUlptRkxOak40VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Vince Martin", "sentiment": "positive"}, {"title": "Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?", "desc": null, "date": "20/09/2019", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2ludmVzdC1pbnZlc2NvLWR5bmFtaWMtYmlvdGVjaG5vbG9neS1nZW5vbWUtMTUwNDAzMzk0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWpNWFUxTVVJelkxcExUM2s0VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": "Sweta Killa", "sentiment": "negative"}, {"title": "Biogen (BIIB) Stock Rally Erases 2019 Alzheimer's Drug Struggle", "desc": null, "date": "05/02/2020", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIwLTAyLTA1L2Jpb2dlbi1zLTExLWJpbGxpb24tYm9vbS1lcmFzZXMtMjAxOS1hbHpoZWltZXItcy1kcnVnLXN0cnVnZ2xl0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTFNVEJwYmtsU2FEUXRURjlSVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Bailey Lipschultz", "sentiment": "negative"}, {"title": "Biogen (BIIB) Q3 Earnings Top, Tecfidera Generics Hurt Sales", "desc": null, "date": "21/10/2020", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vY2Euc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9iaW9nZW4tYmlpYi1xMy1lYXJuaW5ncy10b3AtMTQwMDAyOTI3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5WRzlPZVc5MVlrMW1Zek51VFJDeUFSaWJBaWdCTWdhUlU1S0xwUWM=-w200-h112-p-df", "media": "Yahoo Canada Shine On", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "FDA Accepts Biogen's BLA for Alzheimer's Candidate Aducanumab", "desc": null, "date": "10/08/2020", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvZmRhLWFjY2VwdHMtYmlvZ2Vucy1ibGEtZm9yLWFsemhlaW1lcnMtY2FuZGlkYXRlLWFkdWNhbnVtYWIv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVZVR2cyTVRkSlZYQjFjMTh3VFJEQ0FSaURBaWdCTWdhQlZvb0lJZ2M=-w200-h112-p-df", "media": "Genetic Engineering & Biotechnology News", "site": null, "reporter": "Alex Philippidis", "sentiment": "negative"}, {"title": "Warren Buffett Buys Kroger, Biogen In 4th Quarter", "desc": null, "date": "17/02/2020", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3VydWZvY3VzLzIwMjAvMDIvMTcvd2FycmVuLWJ1ZmZldHQtYnV5cy1rcm9nZXItYmlvZ2VuLWluLTR0aC1xdWFydGVyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTVWRE10VDJSeU4yRlFZVVZEVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": "David Rodeck", "sentiment": "positive"}, {"title": "Is Biogen Stock a Buy?", "desc": null, "date": "15/09/2020", "link": "news.google.com/articles/CBMiQGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA5LzE1L2lzLWJpb2dlbi1zdG9jay1hLWJ1eS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU9MV00yU0ZSVkxYTk5Na3BEVFJDN0FSaU5BaWdCTWdiQk1wd1RtUWs=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen\u2019s Double-WTF Moment, After Trading Halt All Day Friday: The Elusive Alzheimer\u2019s Money", "desc": null, "date": "09/11/2020", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd29sZnN0cmVldC5jb20vMjAyMC8xMS8wOS9iaW9nZW5zLWRvdWJsZS13dGYtY2hhcnQtYWZ0ZXItdHJhZGluZy13YXMtaGFsdGVkLWFsbC1kYXktZnJpZGF5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXJjQzFUWTFkdFRFdEZRa0ZLVFJESUFSajhBU2dCTWdhQkFaQUd0UVk=-w200-h112-p-df", "media": "WOLF STREET", "site": null, "reporter": "Wolf Richter", "sentiment": "negative"}, {"title": "Startup from UC Berkeley CRISPR pioneer Jennifer Doudna lands ALS deal with Biogen - San Francisco Business Times", "desc": null, "date": "06/10/2020", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDIwLzEwLzA2L2plbm5pZmVyLWRvdWRuYS1jcmlzcHItdWMtc2NyaWJlLXRoZXJhcGV1dGljcy1iaWliLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXBOVGMyVTFKRFFYZFdaV2hCVFJDcEFSaXJBaWdCTWdZcFJZQ3ZIUWs=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Ron Leuty", "sentiment": "negative"}, {"title": "Better Buy: AbbVie vs. Biogen", "desc": null, "date": "08/07/2020", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA3LzA4L2JldHRlci1idXktYWJidmllLXZzLWJpb2dlbi5hc3B40gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNWphVlUxTjBVMVQzVlpOamxEVFJDa0FSaXlBaWdCTWdNQkJRWQ=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Stocks to Buy: 10 Companies That Will Benefit From an Aging Population", "desc": null, "date": "28/04/2020", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMC8wNC8xMC1zdG9ja3MtdG8tYnV5LWZvci1hbi1hZ2luZy1wb3B1bGF0aW9uL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXNhekJsWlVnek0zbFZTVGxuVFJDb0FSaXNBaWdCTWdhZGNZSXlxUU0=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Will Ashworth", "sentiment": "negative"}, {"title": "Biogen lifts full-year profit forecast as Tecfidera boosts quarter", "desc": null, "date": "22/07/2020", "link": "news.google.com/articles/CBMiSGh0dHBzOi8vdWsueWFob28uY29tL2ZpbmFuY2UvbmV3cy9iaW9nZW4tcHJvZml0LXJpc2VzLTMtMi0xMTEzMzQyNTYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNHdTSEl0Y0c5bGNsVktialEzVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": "Trisha Roy & Manas Mishra", "sentiment": "negative"}, {"title": "Better Buy: Biogen vs. Amgen", "desc": null, "date": "15/03/2020", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzAzLzE1L2JldHRlci1idXktYmlvZ2VuLXZzLWFtZ2VuLmFzcHjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXhXa0Y0TkdGc2VWVnplR2w2VFJDM0FSaVRBaWdCTWdZSk1vYlZvQWc=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Adria Cimino", "sentiment": "negative"}, {"title": "Biogen to Pit Spinraza Against Novartis' Zolgensma in Phase IV", "desc": null, "date": "22/07/2020", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYmlvZ2VuLXBpdC1zcGlucmF6YS1hZ2FpbnN0LW5vdmFydGlzLTE0MjUwMjkwOS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNHpVSGRJU0hveWNURkhZM3BNVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen/Eisai's New BAN2401 Study for Alzheimer's Begins", "desc": null, "date": "14/07/2020", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vYXUubGlmZXN0eWxlLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYmlvZ2VuLWVpc2Fpcy1iYW4yNDAxLXN0dWR5LWFsemhlaW1lcnMtMTIzMDEyODI2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhVazFWWnpJNFZtTjVhbU55VFJDb0FSaXNBaWdCTWdhbFpKS3NNUWM=-w200-h112-p-df", "media": "Yahoo Lifestyle Australia", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AbbVie Seeks US and EU Nods for Rinvoq for Psoriatic Arthritis", "desc": null, "date": "02/06/2020", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvYWJidmllLXNlZWtzLXVzLWV1LW5vZHMtMTU0MzAzMDU3Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXFMVXRVUzFWRmNXWjBjMmxQVFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Loses $7 Billion in Value on Slow Alzheimer's Drug Rollout", "desc": null, "date": "09/09/2021", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIxLTA5LTA5L2Jpb2dlbi1sb3Nlcy03LWJpbGxpb24taW4tdmFsdWUtb24tc2xvdy1hbHpoZWltZXItZHJ1Zy1yb2xsb3V00gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUdkMUYwV1ZOc1gyZDRaVkpFVFJDb0FSaXNBaWdCTWdZRk1ZeElxUVk=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Cristin Flanagan", "sentiment": "negative"}, {"title": "Mirimus, Inc. Forms Strategic Collaboration with Biogen to Develop RNAi-Based Therapeutics for Neurological Disease ...", "desc": null, "date": "21/07/2021", "link": "news.google.com/articles/CBMitQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL21pcmltdXMtaW5jLWZvcm1zLXN0cmF0ZWdpYy1jb2xsYWJvcmF0aW9uLXdpdGgtYmlvZ2VuLXRvLWRldmVsb3Atcm5haS1iYXNlZC10aGVyYXBldXRpY3MtZm9yLW5ldXJvbG9naWNhbC1kaXNlYXNlLWluZGljYXRpb25zLTMwMTMzODE0OS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXBORVZZY0hkNU1IVmhUVzlOVFJDTEFSaklBU2dCTWdPQk1RQQ=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed as 'big day\" for patients", "desc": null, "date": "07/06/2021", "link": "news.google.com/articles/CBMifGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL3VzLWZkYS1zZXQtcnVsZS1jb250cm92ZXJzaWFsLWJpb2dlbi1hbHpoZWltZXJzLWRydWctMjAyMS0wNi0wNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDRUVGxtVTBRMk5HWXpYM1pSVFJDaUFSaTJBaWdCTWdtRjBZZ0xWV09wVUFF=-w200-h112-p-df", "media": "Reuters", "site": null, "reporter": "Julie Steenhuysen & Deena Beasley", "sentiment": "positive"}, {"title": "Biogen Inc. (BIIB) Stock Jumps 5%: Will It Continue to Soar?", "desc": null, "date": "07/06/2021", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vY2Euc3BvcnRzLnlhaG9vLmNvbS9uZXdzL2Jpb2dlbi1pbmMtYmlpYi1zdG9jay1qdW1wcy0wNjQwMDYxMzYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXVMVkpQV2psTmRuWm1SeTFZVFJEREFSaUNBaWdCTWdZQlE0aEx0UVE=-w200-h112-p-df", "media": "Yahoo Canada Sports", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "5 Top ETFs With Exposure To Biogen | Markets Insider", "desc": null, "date": "07/06/2021", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vbWFya2V0cy5idXNpbmVzc2luc2lkZXIuY29tL25ld3MvZXRmLzUtdG9wLWV0ZnMtd2l0aC1leHBvc3VyZS10by1iaW9nZW4tMTAzMDUwMDk1MNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXJWbTlvYTBnelRHNURiRkZMVFJEQ0FSaURBaWdCTWdrQkVZeEZGcWt6Q2dJ=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Biogen shares surge 38% after FDA approves Alzheimer's drug, the first new therapy for the disease in nearly two decades", "desc": null, "date": "07/06/2021", "link": "news.google.com/articles/CBMihQFodHRwczovL3d3dy5jbmJjLmNvbS8yMDIxLzA2LzA3L2ZkYS1hcHByb3Zlcy1iaW9nZW5zLWFsemhlaW1lcnMtZHJ1Zy10aGUtZmlyc3QtbmV3LXRoZXJhcHktZm9yLXRoZS1kaXNlYXNlLWluLW5lYXJseS10d28tZGVjYWRlcy5odG1s0gGJAWh0dHBzOi8vd3d3LmNuYmMuY29tL2FtcC8yMDIxLzA2LzA3L2ZkYS1hcHByb3Zlcy1iaW9nZW5zLWFsemhlaW1lcnMtZHJ1Zy10aGUtZmlyc3QtbmV3LXRoZXJhcHktZm9yLXRoZS1kaXNlYXNlLWluLW5lYXJseS10d28tZGVjYWRlcy5odG1s?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdSVTVOVW5aV0xXTjNWMlptVFJDb0FSaXNBaWdCTWdZTmtKSm53Z1U=-w200-h112-p-df", "media": "CNBC", "site": null, "reporter": "Berkeley Lovelace & Berkeley Lovelace Jr.", "sentiment": "negative"}, {"title": "Biogen Stock Plunges 40% Since June on Alzheimer's Drug Turmoil", "desc": null, "date": "26/11/2021", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIxLTExLTI2L2Jpb2dlbi1zdG9jay1wbHVuZ2VzLTQwLXNpbmNlLWp1bmUtb24tYWx6aGVpbWVyLXMtZHJ1Zy10dXJtb2ls0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXliRkZFVFZWZlREYzFhMDFPVFJDb0FSaXNBaWdCTWdZRllaQXdLUWc=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Cristin Flanagan", "sentiment": "negative"}, {"title": "3 Better Alzheimer's Drug Stocks to Buy Instead of Biogen", "desc": null, "date": "29/06/2021", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMS8wNi8zLWJldHRlci1hbHpoZWltZXJzLWRydWctc3RvY2tzLXRvLWJ1eS1pbnN0ZWFkLW9mLWJpb2dlbi_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWxRblV0ZDFSTlVtcE5PVFJDVFJDb0FSaXNBaWdCTWdZcEpZYnVvUWc=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Muslim Farooque", "sentiment": "negative"}, {"title": "BMY: 3 Bargain Stocks to Buy and Hold Long Term", "desc": null, "date": "25/10/2021", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2JteS1iaWliLWVyaWMtMy1iYXJnYWluLXN0b2Nrcy10by1idXktYW5kLWhvbGQtbG9uZy10ZXJtL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDVTSHBJYVUxNGNHdG1aSFpoVFJDMUFSaVhBaWdCTWdhdFZJNk9LUVk=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Priyanka Mandal", "sentiment": "negative"}, {"title": "Biogen's XLRP Gene Therapy Fails in Phase 2/3 Clinical Trial", "desc": null, "date": "19/05/2021", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vcGhhcm1hbmV3c2ludGVsLmNvbS9uZXdzL2Jpb2dlbnMteGxycC1nZW5lLXRoZXJhcHktZmFpbHMtaW4tcGhhc2UtMi0zLWNsaW5pY2FsLXRyaWFs0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTBkV2d6TW1GNE1URjFMVFp4VFJDckFSaW5BaWdCTWdNQkV3WQ=-w200-h112-p-df", "media": "PharmaNewsIntel", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen's non-opioid painkiller offers mixed results in phase 2 trial, this time in sensory pain disorder", "desc": null, "date": "16/09/2021", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYmlvZ2VuLXMtdml4b3RyaWdpbmUtZmFpbHMtcGhhc2UtMi1zbWFsbC1maWJlci1uZXVyb3BhdGh5LXRyaWFs0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNHlWMGx3VkVvMWF6ZHRlVUpLVFJDb0FSaXNBaWdCTWdPVkF4Zw=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": "Annalee Armstrong", "sentiment": "negative"}, {"title": "NerveGen (NGEN): 'Biogen (BIIB) Alzheimer drug boosted biotech valuations'", "desc": null, "date": "18/11/2021", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vY2FwaXRhbC5jb20vbmVydmdlbi1uZ2VuLW5ldy1hbHpoZWltZXItZHJ1Zy1jb3VsZC1oYXZlLWJsb2NrYnVzdGVyLXBvdGVudGlhbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWFWWGxCUzJGU2QzcFZlVTVYVFJDM0FSaVRBaWdCTWdhQkZaek5IUWs=-w200-h112-p-df", "media": "Capital.com", "site": null, "reporter": "Jenny Mccall", "sentiment": "negative"}, {"title": "BiiB sprints ahead to connect more people through their running platform", "desc": null, "date": "23/02/2021", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3LmRpZ2l0YWxuZXdzYXNpYS5jb20vYnVzaW5lc3MvYmlpYi1zcHJpbnRzLWFoZWFkLWNvbm5lY3QtbW9yZS1wZW9wbGUtdGhyb3VnaC10aGVpci1ydW5uaW5nLXBsYXRmb3Jt0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXJaemxVUlc1TFVqTkNiSFZzVFJDekFSaWFBaWdCTWdrSllZWm0wbU0xRlFF=-w200-h112-p-df", "media": "Digital News Asia", "site": null, "reporter": "Jee Yee", "sentiment": "positive"}, {"title": "Insurers Don't Want to Pay for Biogen (BIIB) $56,000 Alzheimer\u2019s Drug Aduhelm", "desc": null, "date": "18/11/2021", "link": "news.google.com/articles/CBMia2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIxLTExLTE4L2luc3VyZXJzLWJhbGstYXQtcGF5aW5nLWZvci1iaW9nZW4tYWx6aGVpbWVyLXMtdHJlYXRtZW500gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWtiRTU2VW5JeVlrTkZiWGg0VFJDM0FSaVRBaWdCTWdZQkVKeU9JQWs=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "John Tozzi & Angelica Peebles", "sentiment": "negative"}, {"title": "Apple (AAPL), Biogen to Track Cognitive Health via Wearables", "desc": null, "date": "12/01/2021", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvYXBwbGUtYWFwbC1iaW9nZW4tdHJhY2stY29nbml0aXZlLTE0NTAwMjI1Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUxWVmhLY1RsU2VYQXRVMU5sVFJDeUFSaWJBaWdCTWdhcGRZcnRyUVk=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 Blue-Chip Stocks That Are Ripe to Trade Right Now", "desc": null, "date": "08/07/2021", "link": "news.google.com/articles/CBMiSGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMS8wNy8zLWJsdWUtY2hpcC1zdG9ja3MtdG8tdHJhZGUtcmlnaHQtbm93L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVJSR3hFUkRFNFZEaFBRM1I0VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AC Immune's (ACIU) Stock Up Despite Mixed Data From AD Study", "desc": null, "date": "01/09/2021", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYWMtaW1tdW5lcy1hY2l1LXN0b2NrLWRlc3BpdGUtMTUzMDAzNzU2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVBVVnBGYlVkeVdUZEdSRFpHVFJDUUFSamRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Loses Bid to Revive Patent on Tecfidera MS Drug", "desc": null, "date": "30/11/2021", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIxLTExLTMwL2Jpb2dlbi1sb3Nlcy1iaWQtdG8tcmV2aXZlLXBhdGVudC1vbi10ZWNmaWRlcmEtbXMtZHJ1Z9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUpaeTF3VkRod2EwcGhlR3hwVFJDM0FSaVRBaWdCTWdhaDFJeU14UVE=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Susan Decker & Christopher Yasiejko", "sentiment": "negative"}, {"title": "ANVS Stock: The Huge News Sending Annovis Bio Rocketing 200% Today", "desc": null, "date": "21/05/2021", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMS8wNS9hbnZzLXN0b2NrLXRoZS1odWdlLW5ld3Mtc2VuZGluZy1hbm5vdmlzLWJpby1yb2NrZXRpbmctMjAwLXRvZGF5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNXBUMmsyUjJGbU9FMTFSMjAzVFJDb0FSaXJBaWdCTWdzQkFJYlFGR2V4eWRsaW1n=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Brenden Rearick", "sentiment": "negative"}, {"title": "Newmark announces $476M recaplitalization of 225 Binney Street | Real Estate Weekly", "desc": null, "date": "31/12/2021", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vcmV3LW9ubGluZS5jb20vbmV3bWFyay1hbm5vdW5jZXMtNDc2bS1yZWNhcGxpdGFsaXphdGlvbi1vZi0yMjUtYmlubmV5LXN0cmVldC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNWljRk5CZHkxM1JYTkZjWHBIVFJDbUFSaXZBaWdCTWdPRmdRUQ=-w200-h112-p-df", "media": "Real Estate Weekly", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Biogen Stock Price (BIIB) Jump 43% After Alzheimer\u2019s Drug Win", "desc": null, "date": "28/09/2022", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIyLTA5LTI4L2Jpb2dlbi1hZGRzLTEwLWJpbGxpb24taW4tdmFsdWUtYXMtYWx6aGVpbWVyLXMtd2luLWxpZnRzLXBlZXJz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJOamN4TUcxbk4zQmhTRk0xVFJDM0FSaVRBaWdCTWdZQmtaSlB3UVU=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Bre Bradham", "sentiment": "negative"}, {"title": "EISAI INITIATES BLA SUBMISSION OF DATA FOR LECANEMAB IN CHINA", "desc": null, "date": "22/12/2022", "link": "news.google.com/articles/CBMidWh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvZWlzYWktaW5pdGlhdGVzLWJsYS1zdWJtaXNzaW9uLW9mLWRhdGEtZm9yLWxlY2FuZW1hYi1pbi1jaGluYS0zMDE3MDkzOTcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iLkNnNWZSM1pTZUROaFJXMUVka05GVFJCM0dLa0RLQUV5Q1FHUmpzVzZKazF4QVE=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "BIIB Stock: Is Biogen an investment worth trying now?", "desc": null, "date": "26/10/2022", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYmlpYi1zdG9jay1pcy1iaW9nZW4tYW4taW52ZXN0bWVudC13b3J0aC10cnlpbmctbm93L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDNWbXh2UVcxWFdGSjJWMjVQVFJDaUFoaXVBU2dCTWdtTlFZd1BwYWVLYWdJ=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen shares soar on landmark Alzheimer's data, lift rivals", "desc": null, "date": "28/09/2022", "link": "news.google.com/articles/CBMiiAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9iaW9nZW4tZWlzYWktc3RvY2tzLXNvYXItYWx6aGVpbWVycy1zdWNjZXNzLWxpZnRpbmctcml2YWwtc2hhcmVzLTIwMjItMDktMjgv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNaalJ3VmtrMU5tOUVXVVExVFJDM0FSaVRBaWdCTWdZQlFKakxLQWc=-w200-h112-p-df", "media": "Reuters", "site": null, "reporter": "Natalie Grover & Manas Mishra", "sentiment": "negative"}, {"title": "Biogen Axes Schizophrenia Program, Touts Potential of Next Alzheimer's Drug", "desc": null, "date": "20/07/2022", "link": "news.google.com/articles/CBMicmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2Jpb2dlbi1heGVzLXNjaGl6b3BocmVuaWEtcHJvZ3JhbS10b3V0cy1lYXJseS1wb3RlbnRpYWwtb2YtbmV4dC1hbHpoZWltZXItcy1kcnVnL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUZXalJ0WlVNeVowNDNSWE01VFJDb0FSaXNBaWdCTWdhTjFZenFSUVU=-w200-h112-p-df", "media": "BioSpace", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "8 Stocks That Are High in Quality, Cheap in Price", "desc": null, "date": "21/03/2022", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3Lm1vcm5pbmdzdGFyLmNhL2NhL25ld3MvMjE5Nzk4Lzgtc3RvY2tzLXRoYXQtYXJlLWhpZ2gtaW4tcXVhbGl0eS1jaGVhcC1pbi1wcmljZS5hc3B40gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVliM1ZZWVUxalJVNXBkelY1VFJDM0FSaVRBaWdCTWdPZEl3bw=-w200-h112-p-df", "media": "Morningstar.ca", "site": null, "reporter": "Lauren Solberg", "sentiment": "positive"}, {"title": "Better Alzheimer's Disease Stock: Eli Lilly or Biogen?", "desc": null, "date": "05/10/2022", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzEwLzA1L2JldHRlci1hbHpoZWltZXJzLWRpc2Vhc2Utc3RvY2stZWxpLWxpbGx5LW9yLWJpb2dlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU9hMVJmYWtWMmJuWmpkeTAwVFJDM0FSaVRBaWdCTWdhUlY1Q0hJZ2s=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen's (BIIB) FDA Filing for ALS Drug Gets 3 Months Extension", "desc": null, "date": "18/10/2022", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vYXUubGlmZXN0eWxlLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYmlvZ2Vucy1iaWliLWZkYS1maWxpbmctYWxzLTE1NTAwMzcyNS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJlWE5ETlhaTVpsSnpkMnN6VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle Australia", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "PG: 4 Warren Buffett Stocks to Buy and Never Sell", "desc": null, "date": "23/12/2022", "link": "news.google.com/articles/CBMiYGh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL3BnLWFiYnYtYmlpYi1rci00LXdhcnJlbi1idWZmZXR0LXN0b2Nrcy10by1ob2xkLWludG8tdGhlLW5leHQtZGVjYWRlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTBhRTh0U20xVWFsQmtWbEZCVFJERUFSaUJBaWdCTWdZNWM0UXhNUVk=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Mangeet Kaur", "sentiment": "negative"}, {"title": "Key highlights from Biogen\u2019s (BIIB) Q1 2022 earnings results", "desc": null, "date": "03/05/2022", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20va2V5LWhpZ2hsaWdodHMtZnJvbS1iaW9nZW5zLWJpaWItcTEtMjAyMi1lYXJuaW5ncy1yZXN1bHRzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVdObWhCVG5OcVFtMVVjRWhhVFJDaUFoaXVBU2dCTWdtTlFZd1BwZWVLYWdJ=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "What In The World Is Going On With Biogen (BIIB) Shares?", "desc": null, "date": "28/09/2022", "link": "news.google.com/articles/CBMibWh0dHBzOi8vdWsuaW52ZXN0aW5nLmNvbS9uZXdzL3N0b2NrLW1hcmtldC1uZXdzL3doYXQtaW4tdGhlLXdvcmxkLWlzLWdvaW5nLW9uLXdpdGgtYmlvZ2VuLWJpaWItc2hhcmVzLTI3NjQ3MzPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTJTMmhhZHpkUFgweHRSalYwVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Investing.com UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Agrees to Pay $900 Million to Resolve Kickback Claims", "desc": null, "date": "26/09/2022", "link": "news.google.com/articles/CBMicmh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIyLTA5LTI2L2Jpb2dlbi10by1wYXktOTAwLW1pbGxpb24tb3Zlci1hbGxlZ2VkLWltcHJvcGVyLWRvY3Rvci1wYXltZW50c9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJOamN4TUcxbk4zQmhTRk0xVFJDM0FSaVRBaWdCTWdZQmtaSlB3UVU=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Erik Larson", "sentiment": "negative"}, {"title": "LLY Stock: Why 2023 Could Be Its Year With Obesity, Alzheimer's Treatments", "desc": null, "date": "28/12/2022", "link": "news.google.com/articles/CBMicmh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2xseS1zdG9jay13aHktMjAyMy1jb3VsZC1iZS1pdHMteWVhci13aXRoLW9iZXNpdHktYWx6aGVpbWVycy10cmVhdG1lbnRzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHlRMWROVDNkblVVbFVUamhRVFJDb0FSaXJBaWdCTWdhMUE0aHdFUXM=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "positive"}, {"title": "3 Stocks to Avoid Right Now", "desc": null, "date": "17/11/2022", "link": "news.google.com/articles/CBMicmh0dHBzOi8vd3d3LnRoZWdsb2JlYW5kbWFpbC5jb20vaW52ZXN0aW5nL21hcmtldHMvc3RvY2tzL0lOTy1RL3ByZXNzcmVsZWFzZXMvMTE3NjAwNTUvMy1zdG9ja3MtdG8tYXZvaWQtcmlnaHQtbm93L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVFjRTUyVjFkdk4yc3dkWEIxVFJDdUFSaWlBaWdCTWdNQm9CQQ=-w200-h112-p-df", "media": "The Globe and Mail", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Netizens think Mnet is petty for not apologizing to Cube Entertainment and BTOB", "desc": null, "date": "09/07/2022", "link": "news.google.com/articles/CBMid2h0dHBzOi8vd3d3LmFsbGtwb3AuY29tL2FydGljbGUvMjAyMi8wNy9uZXRpemVucy10aGluay1tbmV0LWlzLXBldHR5LWZvci1ub3QtYXBvbG9naXppbmctdG8tY3ViZS1lbnRlcnRhaW5tZW50LWFuZC1idG9i0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhNVlJsVG01M1oyUmZPRVIyVFJDeEFSaWNBaWdCTWdZQklJUmtHQXM=-w200-h112-p-df", "media": "allkpop", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Where Will Biogen Be in 5 Years?", "desc": null, "date": "20/10/2022", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzEwLzIwL3doZXJlLXdpbGwtYmlvZ2VuLWJlLWluLTUteWVhcnMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWthMmRuVkdKUlJraFZiaTFUVFJDNEFSaVNBaWdCTWdhbE1wQk5IUW8=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "David Jagielski", "sentiment": "positive"}, {"title": "Biogen Picks Drug-Industry Veteran Viehbacher as Its Next CEO", "desc": null, "date": "10/11/2022", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIyLTExLTEwL2Jpb2dlbi1waWNrcy1kcnVnLWluZHVzdHJ5LXZldGVyYW4tdmllaGJhY2hlci1hcy1uZXh0LWNlb9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZkVVZoTUVVeE9HNXhXbkUyVFJEQ0FSaURBaWdCTWdZbGhvanNzUVk=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Marthe Fourcade & Angelica Peebles", "sentiment": "positive"}, {"title": "Ionis' (IONS) Hypercholesterolemia Drug Not to Enter Phase III", "desc": null, "date": "23/09/2022", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL3N0eWxlL2lvbmlzLWlvbnMtaHlwZXJjaG9sZXN0ZXJvbGVtaWEtZHJ1Zy1ub3QtMTgyNjA2OTEwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUhPV3h1VkhsRk1YWkdOMmRmVFJDb0FSaXRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Prothena (PRTA) IND Application Gets FDA Clearance for AD", "desc": null, "date": "29/03/2022", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL3N0eWxlL3Byb3RoZW5hLXBydGEtaW5kLWFwcGxpY2F0aW9uLWdldHMtMTU0NDAzMzIwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDJPRWRVVFRWT2Rrc3lZa0l0VFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Time To Sell Biogen (BIIB) Stock? Limited Potential For Aduhelm", "desc": null, "date": "12/04/2022", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LmFza3RyYWRlcnMuY29tL2FuYWx5c2lzL3RpbWUtdG8tc2VsbC1iaW9nZW4tYmlpYi1zdG9jay1saW1pdGVkLXBvdGVudGlhbC1mb3ItYWR1aGVsbS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5WRWhUWDE5WlJuSnRZVFp5VFJDb0FSaXNBaWdCTWdhaDVJeXN4UVE=-w200-h112-p-df", "media": "AskTraders", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Mnet decides to change the controversial stylization and logo of the 'Street Man Fighter' crew BANK TWO BROTHERS", "desc": null, "date": "08/07/2022", "link": "news.google.com/articles/CBMilgFodHRwczovL3d3dy5hbGxrcG9wLmNvbS9hcnRpY2xlLzIwMjIvMDcvbW5ldC1kZWNpZGVzLXRvLWNoYW5nZS10aGUtY29udHJvdmVyc2lhbC1zdHlsaXphdGlvbi1hbmQtbG9nby1vZi10aGUtc3RyZWV0LW1hbi1maWdodGVyLWNyZXctYmFuay10d28tYnJvdGhlcnPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5XVUZrZGpsVWFGUmFNRVZSVFJDb0FSaXJBaWdCTWdZUlJJcXNJUWc=-w200-h112-p-df", "media": "allkpop", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "BTOB fans angered with Mnet after looking at the dance crew names on 'Street Man Fighter'", "desc": null, "date": "07/07/2022", "link": "news.google.com/articles/CBMif2h0dHBzOi8vd3d3LmFsbGtwb3AuY29tL2FydGljbGUvMjAyMi8wNy9idG9iLWZhbnMtYW5nZXJlZC13aXRoLW1uZXQtYWZ0ZXItbG9va2luZy1hdC10aGUtZGFuY2UtY3Jldy1uYW1lcy1vbi1zdHJlZXQtbWFuLWZpZ2h0ZXLSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpUVGxaWjNsQllqQnVlRE5MVFJDeEFSaWNBaWdCTWdZQklJUmtHQXM=-w200-h112-p-df", "media": "allkpop", "site": null, "reporter": "Sophie Ha", "sentiment": "negative"}, {"title": "[INTERVIEW] Early elimination from 'Street Man Fighter' becomes 'springboard for future success': PrimeKingz", "desc": null, "date": "28/09/2022", "link": "news.google.com/articles/CBMiPGh0dHBzOi8vd3d3LmtvcmVhdGltZXMuY28ua3Ivd3d3L2FydC8yMDI0LzA1LzM5OF8zMzY4ODYuaHRtbNIBP2h0dHBzOi8vbS5rb3JlYXRpbWVzLmNvLmtyL3BhZ2VzL2FydGljbGUuYW1wLmFzcD9uZXdzSWR4PTMzNjg4Ng?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDBUMHR4Y2taQmIzSm9TekZrVFJDM0FSaVRBaWdCTWdtTllaQm10cWM3VEFJ=-w200-h112-p-df", "media": "\ucf54\ub9ac\uc544\ud0c0\uc784\uc2a4", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "[SPOILER] The winner of Mnet's 'Street Man Fighter' revealed", "desc": null, "date": "08/11/2022", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3LmFsbGtwb3AuY29tL2FydGljbGUvMjAyMi8xMS90aGUtd2lubmVyLW9mLW1uZXRzLXN0cmVldC1tYW4tZmlnaHRlci1yZXZlYWxlZNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlTMWRhUkRJd1UzSnNSa2cyVFJDeEFSaWNBaWdCTWdhSmtaTG11QVk=-w200-h112-p-df", "media": "allkpop", "site": null, "reporter": "Sophie Ha", "sentiment": "positive"}, {"title": "Mnet's Trick? 'Street Man Fighter' Addresses BTOB vs BIIB Group Names Issue", "desc": null, "date": "08/07/2022", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3Lmtwb3BzdGFyei5jb20vYXJ0aWNsZXMvMzA3Njc5LzIwMjIwNzA4L21uZXQtdHJpY2stc3RyZWV0LW1hbi1maWdodGVyLWFkZHJlc3Nlcy1idG9iLXZzLWJpaWItZ3JvdXAuaHRt0gF1aHR0cHM6Ly93d3cua3BvcHN0YXJ6LmNvbS9hbXAvYXJ0aWNsZXMvMzA3Njc5LzIwMjIwNzA4L21uZXQtdHJpY2stc3RyZWV0LW1hbi1maWdodGVyLWFkZHJlc3Nlcy1idG9iLXZzLWJpaWItZ3JvdXAuaHRt?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVNhMUZFYldGMlEySnhUMEoyVFJDS0FSajFBU2dCTWdPQklRWQ=-w200-h112-p-df", "media": "Kpopstarz", "site": null, "reporter": "Eunice Dawson", "sentiment": "negative"}, {"title": "'Street Man Fighter' Dance Crew Draws Mixed Reactions From BTOB Fans", "desc": null, "date": "07/07/2022", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3Lmtwb3BzdGFyei5jb20vYXJ0aWNsZXMvMzA3NjYyLzIwMjIwNzA3L3N0cmVldC1tYW4tZmlnaHRlci1kYW5jZS1jcmV3LW1peGVkLXJlYWN0aW9ucy1idG9iLWZhbnMuaHRt0gFyaHR0cHM6Ly93d3cua3BvcHN0YXJ6LmNvbS9hbXAvYXJ0aWNsZXMvMzA3NjYyLzIwMjIwNzA3L3N0cmVldC1tYW4tZmlnaHRlci1kYW5jZS1jcmV3LW1peGVkLXJlYWN0aW9ucy1idG9iLWZhbnMuaHRt?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVNObVZGVDNJMFZGZFlkMnc0VFJDdUFSaWlBaWdCTWdZQklJcWpHQW8=-w200-h112-p-df", "media": "Kpopstarz", "site": null, "reporter": "Robyn Joan", "sentiment": "negative"}, {"title": "\"It has crossed the line,\" \u201cStreet Man Fighter\u201d is in another controversy by provoking BTOB this time", "desc": null, "date": "08/07/2022", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3LmtiaXpvb20uY29tL2l0LWhhcy1jcm9zc2VkLXRoZS1saW5lLXN0cmVldC1tYW4tZmlnaHRlci1pcy1pbi1hbm90aGVyLWNvbnRyb3ZlcnN5LWJ5LXByb3Zva2luZy1idG9iLXRoaXMtdGltZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpObmxsZWpWUmJtUkpZMDEzVFJDdUFSaWhBaWdCTWdZQkVwQWlxZ1k=-w200-h112-p-df", "media": "KBIZoom", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen's (BIIB) Stock Outperforms Industry YTD: Here's Why", "desc": null, "date": "05/09/2023", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW5zLWJpaWItc3RvY2stb3V0cGVyZm9ybXMtaW5kdXN0cnktMTM0MDAwNzU5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpVbWd5TlU1WlRqVTBkek5tVFJDeUFSaWJBaWdCTWdhTk40cUdIZ1k=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen (BIIB) Q3 2023 Earnings Call Transcript", "desc": null, "date": "08/11/2023", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyMy8xMS8wOC9iaW9nZW4tYmlpYi1xMy0yMDIzLWVhcm5pbmdzLWNhbGwtdHJhbnNjcmlwdC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJkblJrUTJWR2FqVlRYMHQyVFJEb0FSalpBU2dCTWdB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "An Intrinsic Calculation For Biogen Inc. (NASDAQ:BIIB) Suggests It's 49% Undervalued", "desc": null, "date": "21/10/2023", "link": "news.google.com/articles/CBMijQFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1iaWliL2Jpb2dlbi9uZXdzL2FuLWludHJpbnNpYy1jYWxjdWxhdGlvbi1mb3ItYmlvZ2VuLWluYy1uYXNkYXFiaWliLXN1Z2dlc3RzLTLSAZEBaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy91cy9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9uYXNkYXEtYmlpYi9iaW9nZW4vbmV3cy9hbi1pbnRyaW5zaWMtY2FsY3VsYXRpb24tZm9yLWJpb2dlbi1pbmMtbmFzZGFxYmlpYi1zdWdnZXN0cy0yL2FtcA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDFUbE5KYVZORmRsTk1WVVY0VFJDSEFSajJBaWdCTWdrVkFKRHBuZWcwd3dJ=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more", "desc": null, "date": "07/07/2023", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjMvMDcvMDcvc3RvY2tzLW1ha2luZy10aGUtYmlnZ2VzdC1wcmVtYXJrZXQtbW92ZXMtLmh0bWzSAVNodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAyMy8wNy8wNy9zdG9ja3MtbWFraW5nLXRoZS1iaWdnZXN0LXByZW1hcmtldC1tb3Zlcy0uaHRtbA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWtPVVZyY21wVlJWVlVOREpTVFJDb0FSaXNBaWdCTWdrUlE1QXZMZWFwUndJ=-w200-h112-p-df", "media": "CNBC", "site": null, "reporter": "Michelle Fox", "sentiment": "negative"}, {"title": "What's Happening With Biogen Stock?", "desc": null, "date": "14/06/2023", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMy8wNi8xNC93aGF0cy1oYXBwZW5pbmctd2l0aC1iaW9nZW4tc3RvY2sv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNDBTaTB6TFhFd09VTmpNM2xzVFJDM0FSaVRBaWdCTWdNQkFBZw=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen (BIIB) Q3 2023 Earnings: Key financials and quarterly highlights", "desc": null, "date": "08/11/2023", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYmlvZ2VuLWJpaWItcTMtMjAyMy1lYXJuaW5ncy1rZXktZmluYW5jaWFscy1hbmQtcXVhcnRlcmx5LWhpZ2hsaWdodHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTNORlpaVW1sVWF6WjJTbFV4VFJDaUFoaXVBU2dCTWdrTlVZd09wU2VxREFJ=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "UNH, HUM, BIIB: 3 Healthcare Stocks to Buy, Say Analysts - TipRanks.com", "desc": null, "date": "07/12/2023", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL2FydGljbGUvdW5oLWh1bS1iaWliLTMtaGVhbHRoY2FyZS1zdG9ja3MtdG8tYnV5LXNheS1hbmFseXN0c9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWxTMFpRTTFoaldDMHllVFpDVFJDbEFSaXhBaWdCTWdrUlFJUk5QYU5VS3dJ=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Joey Frenette", "sentiment": "negative"}, {"title": "Biogen Experimental Alzheimer\u2019s Drug Shows \u2018Favorable Trends\u2019 (BIIB)", "desc": null, "date": "25/10/2023", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTEwLTI1L2Jpb2dlbi1zLWV4cGVyaW1lbnRhbC1hbHpoZWltZXItcy1kcnVnLXNob3dzLWZhdm9yYWJsZS10cmVuZHPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNU9MVTU1TnpoUVluTjJjekZNVFJEQ0FSaURBaWdCTWdrQklZU2ttU0k5NndF=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Robert Langreth & Cynthia Koons", "sentiment": "negative"}, {"title": "Biogen (BIIB) to Report Q3 Earnings: Will It Beat Estimates?", "desc": null, "date": "06/11/2023", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIxNzkwMDMvYmlvZ2VuLWJpaWItdG8tcmVwb3J0LXEzLWVhcm5pbmdzLXdpbGwtaXQtYmVhdC1lc3RpbWF0ZXPSAWVodHRwczovL3d3dy56YWNrcy5jb20vYW1wL3N0b2NrL25ld3MvMjE3OTAwMy9iaW9nZW4tYmlpYi10by1yZXBvcnQtcTMtZWFybmluZ3Mtd2lsbC1pdC1iZWF0LWVzdGltYXRlcw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU1YMlF6Y0ZWVGNWRldNV053VFJESkFSajdBU2dCTWdZTmc1S29NUWM=-w200-h112-p-df", "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Are Biogen Inc.'s (NASDAQ:BIIB) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?", "desc": null, "date": "30/11/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLW5hc2RhcS1iaWliLW1peGVkLTE0MDA0OTI1My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDFUbE5KYVZORmRsTk1WVVY0VFJDSEFSajJBaWdCTWdrVkFKRHBuZWcwd3dJ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen (BIIB) Q2 2023 Earnings Call Transcript", "desc": null, "date": "25/07/2023", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyMy8wNy8yNS9iaW9nZW4tYmlpYi1xMi0yMDIzLWVhcm5pbmdzLWNhbGwtdHJhbnNjcmlwdC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJkblJrUTJWR2FqVlRYMHQyVFJEb0FSalpBU2dCTWdB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen to Buy Reata for $7.3 Billion in Rare-Disease Deal", "desc": null, "date": "28/07/2023", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTA3LTI4L2Jpb2dlbi10by1leHBhbmQtaW4tcmFyZS1kaXNlYXNlcy13aXRoLTctMy1iaWxsaW9uLXJlYXRhLWRlYWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWxhREJXVTI5UFJ6QmhUVGhqVFJDb0FSaXNBaWdCTWdZbGxKS010UVk=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Robert Langreth, Michelle Davis & Dinesh Nair", "sentiment": "negative"}, {"title": "Is Biogen (NASDAQ:BIIB) A Risky Investment?", "desc": null, "date": "15/08/2023", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4tbmFzZGFxLWJpaWItcmlza3ktaW52ZXN0bWVudC0xNDAwMzk1NTEuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDFUbE5KYVZORmRsTk1WVVY0VFJDSEFSajJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Lowers 2023 Earnings Guidance on Costs of Reata Purchase", "desc": null, "date": "08/11/2023", "link": "news.google.com/articles/CBMicmh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTExLTA4L2Jpb2dlbi1sb3dlcnMtMjAyMy1lYXJuaW5ncy1ndWlkYW5jZS1vbi1jb3N0cy1vZi1yZWF0YS1wdXJjaGFzZdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTROemQzTFVsbU1IaGtUakJaVFJDM0FSaVRBaWdCTWdhcHBKU091UVk=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Robert Langreth & Gerry Smith", "sentiment": "negative"}, {"title": "Biogen Inc (BIIB) Reports Mixed Q3 2023 Results and Revises Full-Year Guidance", "desc": null, "date": "08/11/2023", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLWJpaWItcmVwb3J0cy1taXhlZC0yMDA2MTU3NzIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJkNnNWZObEp5ZG5KbFdWOTZSR1J6VFJCakdLY0NLQUV5QTRGQkRB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Here's Why Biogen (NASDAQ:BIIB) Can Manage Its Debt Responsibly", "desc": null, "date": "11/11/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9oZXJlcy13aHktYmlvZ2VuLW5hc2RhcS1iaWliLTExMDAyNjY1Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDFUbE5KYVZORmRsTk1WVVY0VFJDSEFSajJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Biogen Inc. (NASDAQ:BIIB) is favoured by institutional owners who hold 89% of the company", "desc": null, "date": "02/09/2023", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLW5hc2RhcS1iaWliLWZhdm91cmVkLTEzMDAxNzk4Ny5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDFUbE5KYVZORmRsTk1WVVY0VFJDSEFSajJBaWdCTWdrVkFKRHBuZWcwd3dJ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is Biogen Inc (BIIB) Modestly Overvalued? A Comprehensive Valuation Analysis", "desc": null, "date": "08/08/2023", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLWJpaWItbW9kZXN0bHktb3ZlcnZhbHVlZC0xNjM2MTI0MTUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNU1RakEyU0Y5VldqZDFUVTB0VFJDekFSaVpBaWdCTWdNQlVnNA=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Unveiling Biogen (BIIB)'s Value: Is It Really Priced Right? A Comprehensive Guide", "desc": null, "date": "25/09/2023", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy91bnZlaWxpbmctYmlvZ2VuLWJpaWItdmFsdWUtcmVhbGx5LTE1MzkwOTUzMC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXNkVkpOTlZGWE1FMXBabk5yVFJDekFSaVpBaWdCTWdZQlVvNXh1UVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Biogen Inc. (BIIB) Down 0.2% Since Last Earnings Report: Can It Rebound?", "desc": null, "date": "24/08/2023", "link": "news.google.com/articles/CBMiRGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLWJpaWItZG93bi0wLTE1MzA0MTczMS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVRhMjVQZG1OME0xSjRRVXByVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Everything you need to know about Biogen\u2019s (BIIB) Q1 2023 earnings", "desc": null, "date": "25/04/2023", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vZXZlcnl0aGluZy15b3UtbmVlZC10by1rbm93LWFib3V0LWJpb2dlbnMtYmlpYi1xMS0yMDIzLWVhcm5pbmdzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWFVWE5mWDFoNVYxOW1WR0ZzVFJDaUFoaXVBU2dCTWdtTlFZNFBKYWlLYXdJ=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen (BIIB) Weighs Takeover of Drugmaker Reata (RETA)", "desc": null, "date": "28/07/2023", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTA3LTI4L2Jpb2dlbi1pcy1zYWlkLXRvLXdlaWdoLXRha2VvdmVyLW9mLTQtYmlsbGlvbi1kcnVnbWFrZXItcmVhdGHSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWpTalUwT0ZOU1ZrOWlVVlZxVFJDM0FSaVRBaWdCTWdtQkFaN1VnT3lvaUFJ=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Michelle Davis & Dinesh Nair", "sentiment": "negative"}, {"title": "Eisai Presents Latest Analysis of Lecanemab's Effect on Biomarker Changes and Subcutaneous Dosing at The ...", "desc": null, "date": "19/07/2023", "link": "news.google.com/articles/CBMi2QFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2Vpc2FpLXByZXNlbnRzLWxhdGVzdC1hbmFseXNpcy1vZi1sZWNhbmVtYWJzLWVmZmVjdC1vbi1iaW9tYXJrZXItY2hhbmdlcy1hbmQtc3ViY3V0YW5lb3VzLWRvc2luZy1hdC10aGUtYWx6aGVpbWVycy1hc3NvY2lhdGlvbi1pbnRlcm5hdGlvbmFsLWNvbmZlcmVuY2UtYWFpYy0yMDIzLTMwMTg4MTA5NS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWtjalpqYUhOek4xaHVNUzFtVFJDakFSaTJBaWdCTWdZQnNKTEV0Z1k=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Alzheimer's Drug Leqembi Covered for Some Veterans by VA (BIIB)", "desc": null, "date": "13/03/2023", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIzLTAzLTEzL2Vpc2FpLWJpb2dlbi1iaWliLWFsemhlaW1lci1zLWRydWctbGVxZW1iaS10by1nZXQtcGFydGlhbC12YS1jb3ZlcmFnZdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlSV2Q1WXpSNWFVVjZjWGR2VFJDM0FSaVRBaWdCTWdZQnM0aHB4Z1U=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Robert Langreth & John Tozzi", "sentiment": "negative"}, {"title": "BIIB: 3 Stocks to Own as Alzheimer's Drugs Bring Relief", "desc": null, "date": "27/06/2023", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2JpaWItZXNhbHktbGx5LTMtc3RvY2tzLXRvLW93bi1hcy1hbHpoZWltZXJzLWRydWdzLWJyaW5nLXJlbGllZi_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUpTVmhyWm1sMk1XeHFUalJRVFJEaEFSaldBU2dCTWdhaFJJek5wUVU=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Tony Daltorio", "sentiment": "negative"}, {"title": "Better Buy: Biogen vs. Eli Lilly", "desc": null, "date": "29/08/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA4LzI5L2JldHRlci1idXktYmlvZ2VuLXZzLWVsaS1saWxseS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU9hMVJmYWtWMmJuWmpkeTAwVFJDM0FSaVRBaWdCTWdhUlY1Q0hJZ2s=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen (BIIB) Q4 2022 Earnings Call Transcript", "desc": null, "date": "15/02/2023", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyMy8wMi8xNS9iaW9nZW4tYmlpYi1xNC0yMDIyLWVhcm5pbmdzLWNhbGwtdHJhbnNjcmlwdC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJkblJrUTJWR2FqVlRYMHQyVFJEb0FSalpBU2dCTWdB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points", "desc": null, "date": "01/08/2023", "link": "news.google.com/articles/CBMiOmh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8wOC9iaW90ZWNoLXN0b2Nrcy10by1idXktMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRkV1Y0TkZKSGNEbDJiMlJXVFJDb0FSaXNBaWdCTWdhVkVvSlB6UU0=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Joel Baglole", "sentiment": "negative"}, {"title": "Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors Limiting Growth", "desc": null, "date": "27/12/2023", "link": "news.google.com/articles/CBMic2h0dHBzOi8vd3d3Lmd1cnVmb2N1cy5jb20vbmV3cy8yMTQwMTYzL2lzLWJpb2dlbi1pbmMtYmlpYi1zZXQtdG8tdW5kZXJwZXJmb3JtLWFuYWx5emluZy10aGUtZmFjdG9ycy1saW1pdGluZy1ncm93dGjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhWVlJzWVdWRlNHTkRVMmRFVFJESUFSajhBU2dCTWdhbFpKS3RyUVk=-w200-h112-p-df", "media": "GuruFocus.com", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen's 1000-person layoff begins in Cambridge - Boston Business Journal", "desc": null, "date": "17/08/2023", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9ib3N0b24vbmV3cy8yMDIzLzA4LzE3L2xheW9mZnMtYmVnaW4tYmlvZ2VuLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDRSakZ6YURoQ2FGTjBXVmhpVFJDb0FSaXNBaWdCTWdhTjRvZ0l6UU0=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Rowan Walrath", "sentiment": "negative"}, {"title": "Top 3 Healthcare Stock Picks for the New Year", "desc": null, "date": "25/12/2023", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8xMi90b3AtMy1oZWFsdGhjYXJlLXN0b2NrLXBpY2tzLWZvci10aGUtbmV3LXllYXIv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUdSV1YyTkVGak5WVnlkblpLVFJDb0FSaXNBaWdCTWdrTkFJclZtT2VaUUFN=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Charles Munyi", "sentiment": "positive"}, {"title": "Biogen Inc. (BIIB) Dips More Than Broader Markets: What You Should Know", "desc": null, "date": "09/01/2023", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2Jpb2dlbi1pbmMtYmlpYi1kaXBzLW1vcmUtMjMxNTExODcwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUlVSFZzUkZKaFRXNDJTWGd5VFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Inc. (BIIB) Beats Q1 Earnings and Revenue Estimates", "desc": null, "date": "25/04/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvYmlvZ2VuLWluYy1iaWliLWJlYXRzLXExLTEyMjUxMjQ1OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZNM0ZHTVROek1XVkhPR3M1VFJDdUFSaWhBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy", "desc": null, "date": "28/04/2023", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8wNC90aGUtMy1tb3N0LXByb21pc2luZy1iaW90ZWNoLWlubm92YXRpb25zLWluLTIwMjMtYW5kLXRoZS1zdG9ja3MtdG8tYnV5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXRWelpSTkZsSWIyMXdXVlE0VFJDb0FSaXNBaWdCTWdhWk5JeUpIUWs=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Chris Markoch", "sentiment": "positive"}, {"title": "Biogen Inc. (BIIB) Dips More Than Broader Markets: What You Should Know", "desc": null, "date": "19/01/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL3N0eWxlL2Jpb2dlbi1pbmMtYmlpYi1kaXBzLW1vcmUtMjMxNTExODg1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUxiMnhTUTJKRmNrNVFibDlWVFJES0FSajZBU2dCTWdhWmNZeHN1UVU=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?", "desc": null, "date": "28/07/2023", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8wNy93aHktaXMtcmVhdGEtcGhhcm1hY2V1dGljYWxzLXJldGEtc3RvY2stdXAtNTMtdG9kYXkv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUxkSGxTZEVaNGJWSndWMmR0VFJDb0FSaXNBaWdCTWdPSkFnNA=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "William White", "sentiment": "negative"}, {"title": "Biogen (BIIB), Eisai's Lecanemab Gets FDA Nod for Alzheimer's", "desc": null, "date": "09/01/2023", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIwMzY4MDcvYmlvZ2VuLWJpaWItZWlzYWlzLWxlY2FuZW1hYi1nZXRzLWZkYS1ub2QtZm9yLWFsemhlaW1lcnPSAWVodHRwczovL3d3dy56YWNrcy5jb20vYW1wL3N0b2NrL25ld3MvMjAzNjgwNy9iaW9nZW4tYmlpYi1laXNhaXMtbGVjYW5lbWFiLWdldHMtZmRhLW5vZC1mb3ItYWx6aGVpbWVycw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUhPV3h1VkhsRk1YWkdOMmRmVFJDb0FSaXRBaWdCTWdrTkE0WnRpU1diNGdJ=-w200-h112-p-df", "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Novartis comes for a Biogen MS drug with new biosimilar - Boston Business Journal", "desc": null, "date": "25/08/2023", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9ib3N0b24vbmV3cy8yMDIzLzA4LzI1L2Jpb2dlbi10eXNyYWJpLW5vdmFydGlzLXNhbmRvei10eXJ1a28uaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUhjbEZzVEV4cVlUSTVSbVJyVFJEeUFSalFBU2dCTWdZRlFwYnduQWs=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Rowan Walrath", "sentiment": "negative"}, {"title": "Biogen's (NASDAQ:BIIB) investors will be pleased with their favorable 64% return over the last year", "desc": null, "date": "11/05/2023", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2Jpb2dlbnMtbmFzZGFxLWJpaWItaW52ZXN0b3JzLXBsZWFzZWQtMTIwMDI3Njc2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXdlVzVYV1dnNWFuaFVhWEZGVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Biogen (BIIB) to End One of Two Parkinson's Studies on BIIB122", "desc": null, "date": "06/06/2023", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy9iaW9nZW4tYmlpYi1lbmQtb25lLXR3by0xNDU4MDA2NTIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUhPV3h1VkhsRk1YWkdOMmRmVFJDb0FSaXRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Here's Why Biogen Inc. (BIIB) Gained But Lagged the Market Today", "desc": null, "date": "18/03/2024", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9oZXJlcy13aHktYmlvZ2VuLWluYy1iaWliLTIxNTAyMDAwMi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTBTSEZsVkVKRE5tOUthV0pHVFJEYUFSam9BU2dCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen (BIIB) Q4 2023 Earnings Call Transcript", "desc": null, "date": "13/02/2024", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyNC8wMi8xMy9iaW9nZW4tYmlpYi1xNC0yMDIzLWVhcm5pbmdzLWNhbGwtdHJhbnNjcmlwdC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJkblJrUTJWR2FqVlRYMHQyVFJEb0FSalpBU2dCTWdB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "We Think You Can Look Beyond Biogen's (NASDAQ:BIIB) Lackluster Earnings", "desc": null, "date": "21/02/2024", "link": "news.google.com/articles/CBMijAFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1iaWliL2Jpb2dlbi9uZXdzL3dlLXRoaW5rLXlvdS1jYW4tbG9vay1iZXlvbmQtYmlvZ2Vucy1uYXNkYXFiaWliLWxhY2tsdXN0ZXItZdIBkAFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1iaWliL2Jpb2dlbi9uZXdzL3dlLXRoaW5rLXlvdS1jYW4tbG9vay1iZXlvbmQtYmlvZ2Vucy1uYXNkYXFiaWliLWxhY2tsdXN0ZXItZS9hbXA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDFUbE5KYVZORmRsTk1WVVY0VFJDSEFSajJBaWdCTWdrVkFKRHBuZWcwd3dJ=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "BIIB: Biogen (BIIB): Earnings Alert - Key Insights", "desc": null, "date": "12/02/2024", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2JpaWItaW5jeS1leGVsLWNvcnQtYmlvZ2VuLWJpaWItZWFybmluZ3MtYWxlcnQta2V5LWluc2lnaHRzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWFXR1ppTjFsTFgyVmhSa1ZvVFJDNEFSaVNBaWdCTWdZQlFJNHNxUWc=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Aanchal Sugandh", "sentiment": "negative"}, {"title": "Ji Xing acquires Biogen's BIIB131 for acute ischemic stroke", "desc": null, "date": "12/01/2024", "link": "news.google.com/articles/CBMiRmh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL25ld3MvamkteGluZy1iaW9nZW4tYmlpYjEzMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRVRWxPYWs5V2RYTTFSVk5uVFJDc0FSaWxBaWdCTWdZdFlvWlJPUVE=-w200-h112-p-df", "media": "Pharmaceutical Technology", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "BIIB Earnings: Here\u2019s everything you need to know about Biogen\u2019s Q4 report", "desc": null, "date": "13/02/2024", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vYmlpYi1lYXJuaW5ncy1oZXJlcy1ldmVyeXRoaW5nLXlvdS1uZWVkLXRvLWtub3ctYWJvdXQtYmlvZ2Vucy1xNC1yZXBvcnQv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDBOemg0TVVKSVNtMHphRm95VFJDaUFoaXVBU2dCTWdZSlFZd1BxUWM=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Inc. (BIIB) Dips More Than Broader Market: What You Should Know", "desc": null, "date": "25/03/2024", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLWJpaWItZGlwcy1tb3JlLTIxNTAxOTI3OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDFlRWRIY1ZOVWNXUnRiM2xQVFJDMkFSaVVBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "In the wake of Biogen Inc.'s (NASDAQ:BIIB) latest US$1.4b market cap drop, institutional owners may be forced to take severe actions", "desc": null, "date": "13/01/2024", "link": "news.google.com/articles/CBMijAFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1iaWliL2Jpb2dlbi9uZXdzL2luLXRoZS13YWtlLW9mLWJpb2dlbi1pbmNzLW5hc2RhcWJpaWItbGF0ZXN0LXVzMTRiLW1hcmtldC1jYdIBkAFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1iaWliL2Jpb2dlbi9uZXdzL2luLXRoZS13YWtlLW9mLWJpb2dlbi1pbmNzLW5hc2RhcWJpaWItbGF0ZXN0LXVzMTRiLW1hcmtldC1jYS9hbXA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDFUbE5KYVZORmRsTk1WVVY0VFJDSEFSajJBaWdCTWdrVkFKRHBuZWcwd3dJ=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Here's Why Biogen Inc. (BIIB) Fell More Than Broader Market", "desc": null, "date": "28/02/2024", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9oZXJlcy13aHktYmlvZ2VuLWluYy1iaWliLTIyNDUxOTk2Ny5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVdaSGd0V0RkVFdtbzRjMUl3VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is Biogen Inc.'s (NASDAQ:BIIB) Recent Price Movement Underpinned By Its Weak Fundamentals?", "desc": null, "date": "20/03/2024", "link": "news.google.com/articles/CBMiiwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1iaWliL2Jpb2dlbi9uZXdzL2lzLWJpb2dlbi1pbmNzLW5hc2RhcWJpaWItcmVjZW50LXByaWNlLW1vdmVtZW50LXVuZGVycGlubmVk0gGPAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbmFzZGFxLWJpaWIvYmlvZ2VuL25ld3MvaXMtYmlvZ2VuLWluY3MtbmFzZGFxYmlpYi1yZWNlbnQtcHJpY2UtbW92ZW1lbnQtdW5kZXJwaW5uZWQvYW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDFUbE5KYVZORmRsTk1WVVY0VFJDSEFSajJBaWdCTWdrVkFKRHBuZWcwd3dJ=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug", "desc": null, "date": "26/03/2024", "link": "news.google.com/articles/CBMiSGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9jaG1wLWRlbGF5LW5vZC1iaW9nZW4tYmlpYi0xNTIxMDAzNTEuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFjamMwT1ZwMU5tMUxRV05WVFJDeUFSaWJBaWdCTWdZWlU0b3NKUVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Inc. (BIIB) Stock Falls Amid Market Uptick: What Investors Need to Know", "desc": null, "date": "12/03/2024", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLWJpaWItc3RvY2stZmFsbHMtMjE1MDE4MDE1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVJObEo1Y2xoMmVEQjZObGw0VFJDM0FSaVRBaWdCTWdZQlFvNXdOUWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Inc. (BIIB) Laps the Stock Market: Here's Why", "desc": null, "date": "29/01/2024", "link": "news.google.com/articles/CBMiSGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLWJpaWItbGFwcy1zdG9jay0yMjUwMTg0MDEuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVXRWh5YjFGdFdWbGlTa3d0VFJDN0FSaU5BaWdCTWdZbEpZek5tUVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why Is Biogen Inc. (BIIB) Up 2.6% Since Last Earnings Report?", "desc": null, "date": "14/03/2024", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktYmlvZ2VuLWluYy1iaWliLTItMTUzMDM4NjQxLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNTVXRWh5YjFGdFdWbGlTa3d0VFJDN0FSaU5BaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Inc. (BIIB) Stock Sinks As Market Gains: Here's Why", "desc": null, "date": "08/02/2024", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLWJpaWItc3RvY2stc2lua3MtMjI0NTE5Mjc4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXlYMmRpV1VGSFgzQkJXVkZKVFJDb0FSaXNBaWdCTWdZUkpvd01tZ28=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Here's Why Biogen Inc. (BIIB) Fell More Than Broader Market", "desc": null, "date": "05/03/2024", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9oZXJlcy13aHktYmlvZ2VuLWluYy1iaWliLTIyNTAxNzc4MS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVdaSGd0V0RkVFdtbzRjMUl3VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Inc. (NASDAQ:BIIB) Q4 2023 Earnings Call Transcript February 13, 2024", "desc": null, "date": "14/02/2024", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLW5hc2RhcS1iaWliLXE0LTE0MTEzMzE2Ny5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU9hekEzZVU1R1pHMUxRa1psVFJDb0FSaXNBaWdCTWdZaEE0b0xzZ1k=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Insider Monkey", "sentiment": "negative"}, {"title": "Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLWJpaWItZXhwZWN0ZWQtYmVhdC0xNTAwMjk3MTYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXhTVTFFTjJoUWQzQnlaMlpLVFJEaEFSamhBU2dCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biotech Stock Roundup: BIIB's Q4 Results, CBAY Up on GILD's Acquisition & Other Updates", "desc": null, "date": "15/02/2024", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW90ZWNoLXN0b2NrLXJvdW5kdXAtYmlpYnMtcTQtMTMyODAwMTY2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNVRNVTVOY0hkZlluVmZRM2t6VFJDeUFSaWJBaWdCTWdzRkFvZ0tGYVZFWTR0dVV3=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Inc (BIIB) Reports Q4 and Full Year 2023 Results, Anticipates Non-GAAP EPS Growth in 2024", "desc": null, "date": "13/02/2024", "link": "news.google.com/articles/CBMiSGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLWJpaWItcmVwb3J0cy1xNC0xMjM2MDgxOTUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJkNnNWZObEp5ZG5KbFdWOTZSR1J6VFJCakdLY0NLQUV5QTRGQkRB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Here's Why Biogen (NASDAQ:BIIB) Can Manage Its Debt Responsibly", "desc": null, "date": "31/01/2024", "link": "news.google.com/articles/CBMijQFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1iaWliL2Jpb2dlbi9uZXdzL2hlcmVzLXdoeS1iaW9nZW4tbmFzZGFxYmlpYi1jYW4tbWFuYWdlLWl0cy1kZWJ0LXJlc3BvbnNpYmx5LTLSAZEBaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy91cy9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9uYXNkYXEtYmlpYi9iaW9nZW4vbmV3cy9oZXJlcy13aHktYmlvZ2VuLW5hc2RhcWJpaWItY2FuLW1hbmFnZS1pdHMtZGVidC1yZXNwb25zaWJseS0yL2FtcA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDFUbE5KYVZORmRsTk1WVVY0VFJDSEFSajJBaWdCTWdrVkFKRHBuZWcwd3dJ=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Stocks making the biggest moves midday: JetBlue Airways, Shopify, Biogen and more", "desc": null, "date": "13/02/2024", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjQvMDIvMTMvc3RvY2tzLW1ha2luZy10aGUtYmlnZ2VzdC1tb3Zlcy1taWRkYXktamJsdS1zaG9wLWJpaWItYW5kLW1vcmUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5OVGxEV0Y4MU4yOTJiV05SVFJDb0FSaXNBaWdCTWdZQkk2SlFuUW8=-w200-h112-p-df", "media": "CNBC", "site": null, "reporter": "Hakyung Kim", "sentiment": "negative"}, {"title": "BIIB: Buy, Hold, or Sell? Analyzing 3 Biotech Stocks Investors Are Watching", "desc": null, "date": "24/01/2024", "link": "news.google.com/articles/CBMiZGh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2JpaWItYm50eC1rdXJhLWJ1eS1ob2xkLW9yLXNlbGwtYW5hbHl6aW5nLTMtYmlvdGVjaC1zdG9ja3MtaW52ZXN0b3JzLWFyZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtZMmwyWVcxVU1VUnpVR2hzVFJDakFSaTJBaWdCTWdZTkJZS3VrUWs=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Dipanjan Banchur", "sentiment": "negative"}, {"title": "BIIB, ZTS, EXAS: Which \u201cStrong Buy\u201d Healthcare Stock is Best? - TipRanks.com", "desc": null, "date": "13/01/2024", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL2FydGljbGUvYmlpYi16dHMtZXhhcy13aGljaC1zdHJvbmctYnV5LWhlYWx0aGNhcmUtc3RvY2staXMtYmVzdNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVZSSEp3TW00eVRuZFVRVVZZVFJDbEFSaXhBaWdCTWdZZFpaQUtLZ2M=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Joey Frenette", "sentiment": "negative"}, {"title": "Biogen (NASDAQ:BIIB) Notches Up after Dropping Aduhelm - TipRanks.com", "desc": null, "date": "31/01/2024", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL2Jpb2dlbi1uYXNkYXFiaWliLW5vdGNoZXMtdXAtYWZ0ZXItZHJvcHBpbmctYWR1aGVsbdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXdVVlkwWjB0bWRHaFVZaTFZVFJDbEFSaXhBaWdCTWdZVjBJb294Z00=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Steve Anderson", "sentiment": "negative"}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BIIB", "desc": null, "date": "11/03/2024", "link": "news.google.com/articles/CBMinAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3NoYXJlaG9sZGVyLWFsZXJ0LXBvbWVyYW50ei1sYXctZmlybS1pbnZlc3RpZ2F0ZXMtY2xhaW1zLW9uLWJlaGFsZi1vZi1pbnZlc3RvcnMtb2YtYmlvZ2VuLWluYy0tLWJpaWItMzAyMDg1NzA2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNWpRVXhITkdKYU1uaG5XRWhyVFJDaUFSaTJBaWdCTWdNQm9SUQ=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "1 Wall Street Analyst Thinks Biogen Stock Is Going to $311. Is It a Buy Around $223?", "desc": null, "date": "02/03/2024", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDI0LzAzLzAyL3dhbGwtc3RyZWV0LWFuYWx5c3QtYmlvZ2VuLXN0b2NrLTMxMS1idXkv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW1RMUprU2pGMU1XMW9XR2h2VFJDM0FSaVRBaWdCTWdhUnM0NVJ0UVk=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Alex Carchidi", "sentiment": "negative"}, {"title": "Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says", "desc": null, "date": "14/02/2024", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4tY291bGQtZW5nYWdlLTFiLTJiLTIyMTE1NjY1Mi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNW1UazlKYkhRdGVWTTFlR2hoVFJDb0FSaXNBaWdCTWdPRmtSQQ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next", "desc": null, "date": "16/02/2024", "link": "news.google.com/articles/CBMijAFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1iaWliL2Jpb2dlbi9uZXdzL2Jpb2dlbi1pbmMtanVzdC1taXNzZWQtZXBzLWJ5LTIxLWhlcmVzLXdoYXQtYW5hbHlzdHMtdGhpbmstd9IBkAFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS1iaWliL2Jpb2dlbi9uZXdzL2Jpb2dlbi1pbmMtanVzdC1taXNzZWQtZXBzLWJ5LTIxLWhlcmVzLXdoYXQtYW5hbHlzdHMtdGhpbmstdy9hbXA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDFUbE5KYVZORmRsTk1WVVY0VFJDSEFSajJBaWdCTWdrVkFKRHBuZWcwd3dJ=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Can Biogen (BIIB) Keep the Beat Streak Alive in Q4 Earnings?", "desc": null, "date": "08/02/2024", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIyMjM1MTEvY2FuLWJpb2dlbi1iaWliLWtlZXAtdGhlLWJlYXQtc3RyZWFrLWFsaXZlLWluLXE0LWVhcm5pbmdz0gFmaHR0cHM6Ly93d3cuemFja3MuY29tL2FtcC9zdG9jay9uZXdzLzIyMjM1MTEvY2FuLWJpb2dlbi1iaWliLWtlZXAtdGhlLWJlYXQtc3RyZWFrLWFsaXZlLWluLXE0LWVhcm5pbmdz?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpVbWd5TlU1WlRqVTBkek5tVFJDeUFSaWJBaWdCTWdhTk40cUdIZ1k=-w200-h112-p-df", "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Inc. (BIIB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for ...", "desc": null, "date": "14/03/2024", "link": "news.google.com/articles/CBMiuAFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDI0MDMxNDEyMjA5NC9lbi9CaW9nZW4tSW5jLi1CSUlCLUludmVzdGlnYXRpb24tQnJvbnN0ZWluLUdld2lydHotR3Jvc3NtYW4tTExDLUVuY291cmFnZXMtSW52ZXN0b3JzLXRvLVNlZWstQ29tcGVuc2F0aW9uLWZvci1BbGxlZ2VkLVdyb25nZG9pbmdz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpkRmhoVVdaMlQwOTVSbkJsVFJDaUFSaTNBaWdCTWdhaFZKQ0xwUVk=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now", "desc": null, "date": "15/02/2024", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW9nZW4taW5jLWVhcm5pbmdzLW1pc3NlZC1hbmFseXN0LTEwMTQ1MTU5NC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU9NMVpaWkZwTmJtcG1XbmN3VFJDekFSaVpBaWdCTWdZUkFvd1NDUXc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biogen Sales Miss Estimates as Multiple Sclerosis Drugs Decline", "desc": null, "date": "13/02/2024", "link": "news.google.com/articles/CBMicmh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDI0LTAyLTEzL2Jpb2dlbi1zYWxlcy1taXNzLWVzdGltYXRlcy1hcy1tdWx0aXBsZS1zY2xlcm9zaXMtZHJ1Z3MtZGVjbGluZdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTRia3RsVTJ0WWVYZGthbVJGVFJDM0FSaVRBaWdCTWdZUmtaSzB0QVk=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Gerry Smith", "sentiment": "negative"}, {"title": "7 Biotech Stocks Fighting America's Deadliest Diseases", "desc": null, "date": "08/02/2024", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMi83LWJpb3RlY2gtc3RvY2tzLWZpZ2h0aW5nLWFtZXJpY2FzLWRlYWRsaWVzdC1kaXNlYXNlcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVFiRTl2VmtGalFVeFhZVGxaVFJDb0FSaXNBaWdCTWdhVllwTHVLQWc=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Josh Enomoto", "sentiment": "negative"}, {"title": "A Closer Look at 21 Analyst Recommendations For Biogen", "desc": null, "date": "05/03/2024", "link": "news.google.com/articles/CBMicWh0dHBzOi8vbWFya2V0cy5idXNpbmVzc2luc2lkZXIuY29tL25ld3Mvc3RvY2tzL2EtY2xvc2VyLWxvb2stYXQtMjEtYW5hbHlzdC1yZWNvbW1lbmRhdGlvbnMtZm9yLWJpb2dlbi0xMDMzMTMzNTky0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNHRTMjFaTFZvM2NFZHRVR3d5VFJEQ0FSaURBaWdCTWdrQmtJcTBOQ2FTVUFF=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "PRIMECAP Management Bolsters Stake in Biogen Inc", "desc": null, "date": "13/02/2024", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9wcmltZWNhcC1tYW5hZ2VtZW50LWJvbHN0ZXJzLXN0YWtlLWJpb2dlbi0xODA5NTYzMzguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5RVTA1TkhwNVZHMDRaMkoxVFJDX0FSaUhBaWdCTWdhbGs1Q3ROUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits", "desc": null, "date": "04/03/2024", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMy9iaW90ZWNocy1vbi10aGUtcmlzZS0zLXN0b2Nrcy10by1idXktZm9yLWEtc2hvdC1vZi1wcm9maXRzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXRWelpSTkZsSWIyMXdXVlE0VFJDb0FSaXNBaWdCTWdhWk5JeUpIUWs=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Will Ashworth", "sentiment": "negative"}, {"title": "5 Biotech Stocks With 26% Upside Potential or More", "desc": null, "date": "07/03/2024", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LnRyYWRpbmd2aWV3LmNvbS9uZXdzL2JhcmNoYXJ0OjY0NjY2ODY0YTA5NGI6MC01LWJpb3RlY2gtc3RvY2tzLXdpdGgtMjYtdXBzaWRlLXBvdGVudGlhbC1vci1tb3JlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXlWR0U1ZEVGZlNYazJlbFkxVFJDdUFSaWhBaWdCTWdZQlFZYWt6QU0=-w200-h112-p-df", "media": "TradingView", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "5 Best Beaten Down Stocks To Buy Right Now", "desc": null, "date": "25/02/2024", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvNS1iZXN0LWJlYXRlbi1kb3duLXN0b2Nrcy10by1idXktcmlnaHQtbm93LTEyNjE1ODIvNdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWpXVGhYVmpFd09Ha3lTM2RvVFJDb0FSaXNBaWdCTWdrQlVJeGhKbWhyalFF=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": "Ramish Cheema", "sentiment": "positive"}]